{"id":102,"date":"2021-11-15T14:12:40","date_gmt":"2021-11-15T14:12:40","guid":{"rendered":"https:\/\/e-publish.uliege.be\/migraine\/?post_type=back-matter&p=102"},"modified":"2021-12-23T14:23:45","modified_gmt":"2021-12-23T14:23:45","slug":"references","status":"publish","type":"back-matter","link":"https:\/\/e-publish.uliege.be\/migraine\/back-matter\/references\/","title":{"raw":"R\u00e9f\u00e9rences","rendered":"R\u00e9f\u00e9rences"},"content":{"raw":"\u00c1fra\u00a0J., S\u00e1ndor\u00a0P.S. et Schoenen\u00a0J., \u201cHabituation of visual and intensity dependence of auditory evoked cortical potentials tend to normalize just before and during the migraine attack\u201d, Cephalalgia<\/i>, 2000;20:714-719.\r\n\r\nAmbrosini\u00a0A., de Noordhout\u00a0A.M., Sandor\u00a0P.S. et Schoenen\u00a0J., \u201cElectrophysiological studies in migraine: a comprehensive review of their interest and limitations\u201d, Cephalalgia<\/i>, 2003;23:13-31.\r\n\r\nAmbrosini\u00a0A. et Schoenen\u00a0J., \u201cInvasive pericranial nerve interventions\u201d, Cephalalgia<\/i>, 2016\u00a0Oct;36(12):1156-1169.\r\n\r\nAmbrosini\u00a0A., Vandenheede\u00a0M., Rossi\u00a0P., Aloj\u00a0F., Sauli\u00a0E., Pierelli\u00a0F. et Schoenen\u00a0J., \u201cSuboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: a double-blind placebo-controlled study\u201d, Pain<\/i>, 2005;118:92-6.\r\n\r\nAmundsen\u00a0S., Nordeng\u00a0H., Nezvalov\u00e1-Henriksen\u00a0K., Stovner\u00a0L.J. et Spigset\u00a0O., \u201cPharmacological treatment of migraine during pregnancy and breastfeeding\u201d, Nat Rev Neurol<\/i>, 2015\u00a0Apr;11(4):209-19.\r\n\r\nAshina\u00a0M., \u201cMigraine\u201d, N Engl J Med<\/i>, 2020\u00a0Nov\u00a05;383(19):1866-1876.\r\n\r\nAshina\u00a0M., Buse\u00a0D.C., Ashina\u00a0H., Pozo-Rosich\u00a0P., Peres\u00a0M.F.P., Lee\u00a0M.J., Terwindt\u00a0G.M., Halker Singh\u00a0R., Tassorelli\u00a0C., Do\u00a0T.P., Mitsikostas\u00a0D.D. et Dodick\u00a0D.W., \u201cMigraine: integrated approaches to clinical management and emerging treatments\u201d, Lancet<\/i>, 2021\u00a0Apr\u00a017;397(10283):1505-1518.\r\n\r\nBarrett\u00a0C.F., van den Maagdenberg\u00a0A.M.J.M., Frants\u00a0R.R. et Ferrari\u00a0M.D., \u201cFamilial hemiplegic migraine\u201d, Adv Genet<\/i>, 2008;63:57-83.\r\n\r\nBendik\u00a0E.M., Tinkle\u00a0B.T., Al-Shuik\u00a0E., Levin\u00a0L., Martin\u00a0A., Thaler\u00a0R., Atzinger\u00a0C.L., Rueger\u00a0J. et Martin\u00a0V.T., \u201cJoint hypermobility syndrome: A common clinical disorder associated with migraine in women\u201d, Cephalalgia<\/i>, 2011\u00a0Apr;31(5):603-13.\r\n\r\nBogdanov\u00a0V.B., Multon\u00a0S., Chauvel\u00a0V., Bogdanova\u00a0O.V., Prodanov\u00a0D., Makarchuk\u00a0M.Y. et Schoenen\u00a0J., \u201cMigraine preventive drugs differentially affect cortical spreading depression in rat\u201d, Neurobiology of Disease<\/i>, 2011;41:430-435.\r\n\r\nBogdanov\u00a0V.B., Vigan\u00f2\u00a0A., Noirhomme\u00a0Q., Bogdanova\u00a0O.V., Guy\u00a0N., Laureys\u00a0S., Renshaw\u00a0P.F., Dallel\u00a0R., Phillips\u00a0C. et Schoenen\u00a0J., \u201cCerebral responses and role of the prefrontal cortex in conditioned pain modulation: an fMRI study in healthy subjects\u201d, Behav Brain Res<\/i>, 2015\u00a0Mar\u00a015;281:187-98.\r\n\r\nBreslau N, Davis GC. Migraine, physical health and psychiatric disorder: a prospective epidemiologic study in young adults, J Psychiatr Res.,<\/i> 1993 Apr-Jun;27(2):211-21.\r\n\r\nBurch\u00a0R., Rizzoli\u00a0P. et Loder\u00a0E., \u201cThe prevalence and impact of migraine and severe headache in the United States: Updated age, sex, and socioeconomic-specific estimates from government health surveys\u201d, Headache<\/i>, 2021\u00a0Jan;61(1):60-68.\r\n\r\nBurstein\u00a0R., Noseda\u00a0R. et Fulton\u00a0A.B., \u201cNeurobiology of Photophobia\u201d, J\u00a0Neuroophthalmol<\/i>, 2019\u00a0Mar;39(1):94-102.\r\n\r\nChalmer\u00a0M.A., Esserlind\u00a0A.L., Olesen\u00a0J. et Hansen\u00a0T.F., \u00ab\u00a0Polygenic risk score: use in migraine research\", J\u00a0Headache Pain<\/i>, 2018\u00a0Apr\u00a05;19(1):29.\r\n\r\nCharles\u00a0A., et Hansen\u00a0J.M., \u201cMigraine aura: new ideas about cause, classification, and clinical significance\u201d, Curr Opin Neurol<\/i>, 2015\u00a0Jun;28(3):255-60.\r\n\r\nChauvel\u00a0V., Multon\u00a0S. et Schoenen\u00a0J., \u201cEstrogen-dependent effects of 5-hydroxytryptophan on cortical spreading depression in rat: modelling the serotonin-ovarian hormone interaction in migraine aura\u201d, Cephalalgia<\/i>, 2018\u00a0Mar;38(3):427-436.\r\n\r\nChauvel\u00a0V., Schoenen\u00a0J. et Multon\u00a0S. (J.S. and S.M. contributed equally to this work<\/i>), \u201cInfluence of Ovarian Hormones on Cortical Spreading Depression and Its Suppression by L-kynurenine in Rat\u201d, PLoS ONE<\/i>, 2013;8(12): e82279.\r\n\r\nChoquet\u00a0H., Yin\u00a0J., Jacobson\u00a0A.S., Horton\u00a0B.H., Hoffmann\u00a0T.J., Jorgenson\u00a0E., Avins\u00a0A.L. et Pressman\u00a0A.R., \u201cNew and sex-specific migraine susceptibility loci identified from a multiethnic genome-wide meta-analysis\u201d, Commun Biol<\/i>, 2021\u00a0Jul\u00a022;4(1):864.\r\n\r\nChou\u00a0D.E., Shnayderman Yugrakh\u00a0M., Winegarner\u00a0D., Rowe\u00a0V., Kuruvilla\u00a0D. et Schoenen\u00a0J., \u201cAcute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial\u201d, Cephalalgia<\/i>, 2019\u00a0Jan;39(1):3-14.\r\n\r\nCoppola\u00a0G., Di Lenola\u00a0D., Abagnale\u00a0C., Ferrandes\u00a0F., Sebastianelli\u00a0G., Casillo\u00a0F., Di Lorenzo\u00a0C., Serrao\u00a0M., Evangelista\u00a0M., Schoenen\u00a0J. et Pierelli\u00a0F., \u201cShort-latency afferent inhibition and somato-sensory evoked potentials during the migraine cycle: surrogate markers of a cycling cholinergic thalamo-cortical drive?\u201d, J\u00a0Headache Pain<\/i>, 2020\u00a0Apr\u00a016;21(1):34.\r\n\r\nDelvaux\u00a0V., Vandenheede\u00a0M. et Schoenen\u00a0J., \u00ab\u00a0C\u00e9phal\u00e9es explosives, \u201cen coup de tonnerre\u201d\u00a0: faut-il s\u2019inqui\u00e9ter\u00a0?\u00a0\u00bb, Revue m\u00e9dicale de Li\u00e8ge<\/i>, 2000, 55:910-914.\r\n\r\nDemarquay\u00a0G., Moisset\u00a0X., Lant\u00e9ri-Minet\u00a0M., de Gaalon\u00a0S., Donnet\u00a0A., Giraud\u00a0P., Gu\u00e9gan-Massardier\u00a0E., Lucas\u00a0C., Mawet\u00a0J., Roos\u00a0C., Valade\u00a0D. et Ducros\u00a0A., \u201cRevised guidelines of the French Headache Society for the diagnosis and management of migraine in adults. Part\u00a01: Diagnosis and assessment\u201d, Rev.\u00a0Neurol.<\/i>, Paris, 2021\u00a0Sep;177(7):725-733.\r\n\r\nDenuelle\u00a0M., Fabre\u00a0N., Payoux\u00a0P., Chollet\u00a0F. et Geraud\u00a0G., \u201cHypothalamic activation in spontaneous migraine attacks\u201d, Headache<\/i>, 2007\u00a0Nov-Dec;47(10):1418-26.\r\n\r\nDi Lorenzo\u00a0C., Pinto\u00a0A., Ienca\u00a0R., Coppola\u00a0G., Sirianni\u00a0G., Di Lorenzo\u00a0G., Parisi\u00a0V., Serrao\u00a0M., Spagnoli\u00a0A., Vestri\u00a0A., Schoenen\u00a0J., Donini\u00a0L.M. et Pierelli\u00a0F., \u201cA Randomized Double-Blind, Cross-Over Trial of very Low-Calorie Diet in Overweight Migraine Patients: A Possible Role for Ketones?\u201d, Nutrients<\/i>, 2019\u00a0Jul\u00a028;11(8):1742.\r\n\r\nDi Stefano\u00a0G., Yuan\u00a0J.H., Cruccu\u00a0G., Waxman\u00a0S.G., Dib-Hajj\u00a0S.D. et Truini\u00a0A., \u201cFamilial trigeminal neuralgia\u00a0\u2013\u00a0a systematic clinical study with a genomic screen of the neuronal electrogenisome\u201d, Cephalalgia<\/i>, 2020\u00a0Jul;40(8):767-777.\r\n\r\nDiener\u00a0H.C., Dodick\u00a0D., Evers\u00a0S., Holle\u00a0D., Jensen\u00a0R.H., Lipton\u00a0R.B., Porreca\u00a0F., Silberstein\u00a0S. et Schwedt\u00a0T., \u201cPathophysiology, prevention, and treatment of medication overuse headache\u201d, Lancet Neurol<\/i>, 2019\u00a0Sep;18(9):891-902.\r\n\r\nDiener\u00a0H.C., MacGregor\u00a0E.A., Schoenen\u00a0J., Steiner\u00a0T.J., Muirhead\u00a0N. et Sikes\u00a0C., \u201cComparison of the efficacy and safety of eletriptan and zolmitriptan for the acute treatment of migraine: results of a multicenter, multi-dose, randomised clinical trial\u201d, Neurology<\/i>, 2002, 58, Suppl.\u00a03, A290:P04.081.\r\n\r\nDodick\u00a0D.W., \u201cCGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications\u201d, Cephalalgia<\/i>, 2019\u00a0Mar;39(3):445-458.\r\n\r\nDrellia\u00a0K., Kokoti\u00a0L., Deligianni\u00a0C.I., Papadopoulos\u00a0D. et Mitsikostas\u00a0D.D., \u00ab\u00a0Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis\", Cephalalgia<\/i>, 2021\u00a0Jun;41(7):851-864.\r\n\r\nDucros\u00a0A., de Gaalon\u00a0S., Roos\u00a0C., Donnet\u00a0A., Giraud\u00a0P., Gu\u00e9gan-Massardier\u00a0E., Lant\u00e9ri-Minet\u00a0M., Lucas\u00a0C., Mawet\u00a0J., Moisset\u00a0X., Valade\u00a0D. et Demarquay\u00a0G., \u201cRevised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part\u00a02: Pharmacological treatment\u201d, Rev Neurol<\/i>, Paris, 2021\u00a0Sep;177(7):734-752.\r\n\r\nEadie\u00a0M.J., \u201cHubert Airy, contemporary men of science and the migraine aura\u201d, J\u00a0R\u00a0Coll Physicians Edinb., 2009;39:263-7.\r\n\r\nEdmeads\u00a0J., L\u00e1inez\u00a0J.M., Brandes\u00a0J.L., Schoenen\u00a0J. et Freitag\u00a0F., \u201cPotential of the migraine disability assessment (MIDAS) questionnaire as a public health initiative and in clinical practice\u201d, Neurology<\/i>, 2001, 56 (Suppl\u00a01):S29-S34.\r\n\r\nEdvinsson\u00a0L., Haanes\u00a0K.A., Warfvinge\u00a0K. et Krause\u00a0D.N., \u00ab\u00a0CGRP as the target of new migraine therapies\u00a0\u2013\u00a0successful translation from bench to clinic\", Nat Rev Neurol<\/i>, 2018;14(6):338-350.\r\n\r\nEigenbrodt\u00a0A.K., Ashina\u00a0H., Khan\u00a0S., Diener\u00a0H.C., Mitsikostas\u00a0D.D., Sinclair\u00a0A.J., Pozo-Rosich\u00a0P., Martelletti\u00a0P., Ducros\u00a0A., Lant\u00e9ri-Minet\u00a0M., Braschinsky\u00a0M., Del Rio\u00a0M.S., Daniel\u00a0O., \u00d6zge\u00a0A., Mammadbayli\u00a0A., Arons\u00a0M., Skorobogatykh\u00a0K., Romanenko\u00a0V., Terwindt\u00a0G.M., Paemeleire\u00a0K., Sacco\u00a0S., Reuter\u00a0U., Lampl\u00a0C., Schytz\u00a0H.W., Katsarava\u00a0Z., Steiner\u00a0T.J. et Ashina\u00a0M., \u201cDiagnosis and management of migraine in ten steps\u201d, Nat Rev Neurol<\/i>, 2021\u00a0Aug;17(8):501-514.\r\n\r\nF\u00e4rkkil\u00e4\u00a0M., Diener\u00a0H.C., G\u00e9raud\u00a0G., L\u00e1inez\u00a0M., Schoenen\u00a0J., Harner\u00a0N., Pilgrim\u00a0A. et Reuter\u00a0U. (for the COL\u00a0MIG-202 study group), \u201cEfficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase\u00a02 randomised, placebo-controlled, parallel-group, dose-ranging study\u201d, Lancet Neurology<\/i>, 2012;11:405-413.\r\n\r\nFern\u00e1ndez-de-las-Pe\u00f1as\u00a0C., Chaitow\u00a0L. et Schoenen\u00a0J., \u201cMultidsiciplinary Management of Migraine: Pharmacological, Manual And Other Therapies\u201d, Ed. Jones and Bartlett Learning (USA), Contemporary issues in physical therapy and rehabilitation medicine<\/i>, 2012, 414\u00a0p.\r\n\r\nFern\u00e1ndez-de-Las-Pe\u00f1as\u00a0C. et Cuadrado\u00a0M.L., \u201cPhysical therapy for headaches\u201d, Cephalalgia<\/i>, 2016\u00a0Oct;36(12):1134-1142.\r\n\r\nFogang\u00a0Y., G\u00e9rard\u00a0P., De Pasqua\u00a0V., Pepin\u00a0J.L., Ndiaye\u00a0M., Magis\u00a0D. et Schoenen\u00a0J., \u201cAnalysis and clinical correlates of 20\u00a0Hz photic driving on routine EEG in migraine\u201d, Acta Neurol Belg<\/i>, 2015\u00a0Mar;115(1):39-45.\r\n\r\nFontana\u00a0A., \u00ab\u00a0Essai contr\u00f4l\u00e9 randomis\u00e9\u00a0: quelle est la plus-value de l\u2019assistance vid\u00e9o lors de s\u00e9ances d\u2019\u00e9ducation th\u00e9rapeutique chez les patients migraineux\u00a0\u00bb, M\u00e9moire de fin d\u2019\u00e9tudes de Master en sciences de la sant\u00e9 publique, ULg, ann\u00e9e acad\u00e9mique 2018-2019.\r\n\r\nFumal\u00a0A., Laureys\u00a0S., Di Clemente\u00a0L., Boly\u00a0M., Bohotin\u00a0V., Vandenheede\u00a0M., Coppola\u00a0G., Salmon\u00a0E., Kupers\u00a0R. et Schoenen\u00a0J., \u201cOrbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine\u201d, Brain<\/i>, 2006;129:543-50.\r\n\r\nFumal\u00a0A., Magis\u00a0D. et Schoenen\u00a0J., \u00ab\u00a0Les c\u00e9phal\u00e9es par abus d\u2019antalgiques\u00a0\u00bb, Revue m\u00e9dicale de Li\u00e8ge<\/i>, 2006, 61(4):217-222.\r\n\r\nGaul\u00a0C., S\u00e1ndor\u00a0P.S., Galli\u00a0U., Palla\u00a0S. et Ettlin\u00a0D.A., \u201cOrofacial migraine\u201d, Cephalalgia<\/i>, 2007\u00a0Aug;27(8)\u00a0:950-2.\r\n\r\nGeorge\u00a0K.M., Folsom\u00a0A.R., Sharrett\u00a0A.R., Mosley\u00a0T.H., Gottesman\u00a0R.F., Hamedani\u00a0A.G. et Lutsey\u00a0P.L., \u201cMigraine Headache and Risk of Dementia in the Atherosclerosis Risk in Communities Neurocognitive Study\u201d, Headache<\/i>, 2020\u00a0May;60(5):946-953.\r\n\r\nG\u00e9rardy\u00a0P.-Y., Fumal\u00a0A. et Schoenen\u00a0J., \u00ab\u00a0\u00c9pid\u00e9miologie et r\u00e9percussions \u00e9conomiques des c\u00e9phal\u00e9es\u00a0: une enqu\u00eate parmi le personnel administratif, technique et ouvrier (PATO) de l\u2019Universit\u00e9 de Li\u00e8ge\u00a0\u00bb, Revue m\u00e9dicale de Li\u00e8ge<\/i>, 2008, 63\u00a0:310-314.\r\n\r\nGlobal burden of 369\u00a0diseases and injuries in 204\u00a0countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019, GBD\u00a02019 Diseases and Injuries Collaborators, Lancet, 2020\u00a0Oct\u00a017;396(10258):1204-1222.\r\n\r\nGross\u00a0E.C., Klement\u00a0R.J., Schoenen\u00a0J., D\u2019Agostino\u00a0D.P. et Fischer\u00a0D., \u201cPotential Protective Mechanisms of Ketone Bodies in Migraine Prevention\u201d, Nutrients<\/i>, 2019\u00a0Apr\u00a010;11(4):811.\r\n\r\nGross\u00a0E.C., Lisicki\u00a0M., Fischer\u00a0D., S\u00e1ndor\u00a0P.S. et Schoenen\u00a0J., \u201cThe metabolic face of migraine\u00a0\u2013\u00a0from pathophysiology to treatment\u201d, Nat Rev Neurol<\/i>, 2019\u00a0Nov;15(11):627-643.\r\n\r\nHeadache Classification Committee of the International Headache Society (IHS), The International Classification of Headache Disorders<\/i>, 3rd<\/sup>\u00a0ed., Cephalalgia, 2018\u00a0Jan;38(1):1-211.\r\n\r\nHepp\u00a0Z., Dodick\u00a0D.W., Varon\u00a0S.F., Chia\u00a0J., Matthew\u00a0N., Gillard\u00a0P., Hansen\u00a0R.N. et Devine\u00a0E.B., \u201cPersistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis\u201d, Cephalalgia<\/i>, 2017\u00a0Apr;37(5):470-485.\r\n\r\nHolroyd\u00a0K.A., Cottrell\u00a0C.K., O\u2019Donnell\u00a0F.J., Cordingley\u00a0G.E., Drew\u00a0J.B., Carlson\u00a0B.W. et Himawan\u00a0L., \u201cEffect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial\u201d, BMJ<\/i>, 2010\u00a0Sep\u00a029;341:c4871.\r\n\r\nHorton\u00a0B.T., MacLean\u00a0A.R. et Craig\u00a0W.M., \u201cA new syndrome of vascular headache: results of treatment with histamine: preliminary report\u201d, Mayo Clinic Proceedings<\/i>, 1939;14:257.\r\n\r\nJuprelle\u00a0M. et Schoenen\u00a0J., \u00ab\u00a0Relaxation avec biofeedback<\/i> musculaire dans les c\u00e9phal\u00e9es de type tension\u00a0: analyse multifactorielle d\u2019un groupe de 31\u00a0patients\u00a0\u00bb, Revue m\u00e9dicale de Li\u00e8ge<\/i>, 1990;45:630-637.\r\n\r\nKelman\u00a0L., \u201cThe triggers or precipitants of the acute migraine attack\u201d, Cephalalgia<\/i>, 2007\u00a0May;27(5):394-402.\r\n\r\nKosinski\u00a0M., Bayliss\u00a0M.S., Bjorner\u00a0J.B. et\u00a0al<\/i>., \u201cA six\u2010item short\u2010form survey for measuring headache impact: The HIT\u20106\u201d, Qual Life Res<\/i>, 2003;12:963\u2010974.\r\n\r\nKostev\u00a0K., Bohlken\u00a0J. et Jacob\u00a0L., \u201cAssociation Between Migraine Headaches and Dementia in More than 7,400\u00a0Patients Followed in General Practices in the United Kingdom\u201d, J\u00a0Alzheimers Dis<\/i>, 2019;71(1):353-360.\r\n\r\nKurth\u00a0T. et Diener\u00a0H.C., \u201cCurrent views of the risk of stroke for migraine with and migraine without aura\u201d, Curr Pain Headache Rep<\/i>, 2006\u00a0Jun;10(3):214-20.\r\n\r\nKurth\u00a0T., Rist\u00a0P.M., Ridker\u00a0P.M., Kotler\u00a0G., Bubes\u00a0V. et Buring\u00a0J.E., \u201cAssociation of Migraine With Aura and Other Risk Factors With Incident Cardiovascular Disease in Women\u201d, JAMA<\/i>, 2020\u00a0Jun\u00a09;323(22):2281-2289.\r\n\r\nKurth\u00a0T., Winter\u00a0A.C., Eliassen\u00a0A.H., Dushkes\u00a0R., Mukamal\u00a0K.J., Rimm\u00a0E.B., Willett\u00a0W.C., Manson\u00a0J.E. et Rexrode\u00a0K.M., \u201cMigraine and risk of cardiovascular disease in women: prospective cohort study\u201d, BMJ<\/i>, 2016\u00a0May\u00a031;353:i2610.\r\n\r\nLaakso\u00a0S.M., Hekali\u00a0O., Kurdo\u00a0G., Martola\u00a0J., Sairanen\u00a0T. et Atula\u00a0S., \u201cTrigeminal neuralgia in multiple sclerosis: Prevalence and association with demyelination\u201d, Acta Neurol Scand<\/i>, 2020\u00a0Aug;142(2):139-144.\r\n\r\nLanteri-Minet\u00a0M., Valade\u00a0D., Geraud\u00a0G., Lucas\u00a0C. et Donnet\u00a0A., \u201cRevised French guidelines for the diagnosis and management of migraine in adults and children\u201d, J\u00a0Headache Pain<\/i>, 2014\u00a0Jan\u00a08;15(1):2.\r\n\r\nLauritzen\u00a0M., \u201cCortical spreading depression in migraine\u201d, Cephalalgia<\/i>, 2001\u00a0Sep;21(7):757-60.\r\n\r\nLempert\u00a0T., Olesen\u00a0J., Furman\u00a0J., Waterston\u00a0J., Seemungal\u00a0B., Carey\u00a0J., Bisdorff\u00a0A., Versino\u00a0M., Evers\u00a0S. et Newman-Toker\u00a0D., \u00ab\u00a0Vestibular migraine: diagnostic criteria\u00a0\u00bb, J\u00a0Vestib Res<\/i>, 2012;22(4):167-72.\r\n\r\nLinde\u00a0K., Allais\u00a0G., Brinkhaus\u00a0B., Fei\u00a0Y., Mehring\u00a0M., Vertosick\u00a0E.A., Vickers\u00a0A. et White\u00a0A.R., \u201cAcupuncture for the prevention of episodic migraine\u201d, Cochrane Database Syst Rev<\/i>, 2016\u00a0Jun\u00a028;2016(6):CD001218.\r\n\r\nLipton\u00a0R.B., Bigal\u00a0M.E., Ashina\u00a0S., Burstein\u00a0R., Silberstein\u00a0S., Reed\u00a0M.L., Serrano\u00a0D. et Stewart\u00a0W.F., \u201cAmerican Migraine Prevalence Prevention Advisory Group. Cutaneous allodynia in the migraine population\u201d, Ann Neurol<\/i>, 2008\u00a0Feb;63(2):148-58.\r\n\r\nLipton\u00a0R.B., Cady\u00a0R.K., Stewart\u00a0W.F., Wilks\u00a0K. et Hall\u00a0C., \u201cDiagnostic lessons from the spectrum study\u201d, Neurology<\/i>, 2002\u00a0May\u00a014;58(9\u00a0Suppl\u00a06):S27-31.\r\n\r\nLipton\u00a0R.B., Scher\u00a0A.I., Kolodner\u00a0K., Liberman\u00a0J., Steiner\u00a0T.J. et Stewart\u00a0W.F., \u201cMigraine in the United States: epidemiology and patterns of health care use\u201d, Neurology<\/i>, 2002;58:885-894.\r\n\r\nLisicki\u00a0M. et Schoenen\u00a0J., \u201cMetabolic treatments of migraine\u201d, Expert Review of Neurotherapeutics<\/i>, 2020;20(3):295-302.\r\n\r\nLisicki\u00a0M. et Schoenen\u00a0J., \u201cOld habits die hard: Dietary patterns of migraine patients challenge our understanding of dietary triggers\u201d, Front Neurol<\/i>, 2021 (sous presse).\r\n\r\nLipton\u00a0R.B., Stewart\u00a0W.F., Sawyer\u00a0J. et Edmeads\u00a0J.G., \u201cClinical utility of an instrument assessing migraine disability: the Migraine Disability Assessment (MIDAS) questionnaire\u201d, Headache<\/i>, 2001\u00a0Oct;41(9):854-61.\r\n\r\nLisicki\u00a0M., D\u2019Ostilio\u00a0K., Coppola\u00a0G., Scholtes\u00a0F., Maertens de Noordhout\u00a0A., Parisi\u00a0V., Schoenen\u00a0J. et Magis\u00a0D., \u201cEvidence of an increased neuronal activation-to-resting glucose uptake ratio in the visual cortex of migraine patients: a study comparing 18FDG-PET and visual evoked potentials\u201d, J\u00a0Headache Pain<\/i>, 2018\u00a0Jul\u00a05;19(1):49.\r\n\r\nLoder\u00a0E.W., \u201cMenstrual migraine: pathophysiology, diagnosis, and impact\u201d, Headache<\/i>, 2006\u00a0Oct;46\u00a0Suppl\u00a02:S55-60.\r\n\r\nMacGregor\u00a0E.A., \u201cMenstrual migraine\u201d, Curr Opin Neurol<\/i>, 2008\u00a0Jun;21(3):309-15.\r\n\r\nMaertens de Noordhout\u00a0A. et Schoenen\u00a0J., \u00ab\u00a0Les algies faciales\u00a0\u00bb, Revue m\u00e9dicale de Li\u00e8ge<\/i>, 1986, XLI(9)\u00a0:342-348.\r\n\r\nMaertens de Noordhout\u00a0A., Timsit\u00a0M., Timsit-Berthier\u00a0M. et Schoenen\u00a0J., \u201cContingent Negative Variation in Headache\u201d, Annals of Neurology<\/i>, 1986;19:78-80.\r\n\r\nMagis\u00a0D., Gerardy\u00a0P.Y., Remacle\u00a0J.M. et Schoenen\u00a0J., \u201cSustained effectiveness of occipital nerve stimulation in drug-resistant chronic cluster headache\u201d, Headache<\/i>, 2011;51:1191-201.\r\n\r\nMagis\u00a0D. et Schoenen\u00a0J., \u201cMigraine: from genetics to environment\u201d, Revue m\u00e9dicale de Li\u00e8ge<\/i>, 2012, 67:349-358.\r\n\r\nManack\u00a0A.N., Buse\u00a0D.C. et Lipton\u00a0R.B., \u201cChronic migraine: epidemiology and disease burden\u201d, Curr Pain Headache Rep<\/i>, 2011\u00a0Feb;15(1):70-8.\r\n\r\nMitsikostas\u00a0D.D., Mantonakis\u00a0L.I. et Chalarakis\u00a0N.G., \u00ab\u00a0Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches\", Cephalalgia<\/i>, 2011\u00a0Apr;31(5):550-61.\r\n\r\nMoens\u00a0G., Johannik\u00a0K., Verbeek\u00a0C. et Bulterys\u00a0S., \u201cThe prevalence and characteristics of migraine among the Belgian working population\u201d, Acta Neurol Belg<\/i>, 2007\u00a0Sep;107(3):84-90.\r\n\r\nMoskowitz\u00a0M.A., \u201cThe neurobiology of vascular head pain\u201d, Ann Neurol<\/i>, 1984\u00a0Aug;16(2):157-68.\r\n\r\nNappi\u00a0R.E., Sances\u00a0G., Allais\u00a0G., Terreno\u00a0E., Benedetto\u00a0C., Vaccaro\u00a0V., Polatti\u00a0F. et Facchinetti\u00a0F., \u201cEffects of an estrogen-free, desogestrel-containing oral contraceptive in women with migraine with aura: a prospective diary-based pilot study\u201d, Contraception<\/i>, 2011\u00a0Mar;83(3):223-8.\r\n\r\nObermann\u00a0M., Yoon\u00a0M.S., Dommes\u00a0P., Kuznetsova\u00a0J., Maschke\u00a0M., Weimar\u00a0C., Limmroth\u00a0V., Diener\u00a0H.C. et Katsarava\u00a0Z., \u201cPrevalence of trigeminal autonomic symptoms in migraine: a population-based study\u201d, Cephalalgia<\/i>, 2007\u00a0Jun;27(6):504-9.\r\n\r\nOlesen\u00a0J., Diener\u00a0H.C., Schoenen\u00a0J. et Hettiarachchi\u00a0J., \u201cNo effect of eletriptan administration during the aura phase of migraine\u201d, Europ J Neurol<\/i>, 2004;11:671-677.\r\n\r\nOsterhaus\u00a0J.T., Townsend\u00a0R.J., Gandek\u00a0B. et Ware\u00a0J.E.\u00a0Jr., \u201cMeasuring the functional status and well-being of patients with migraine headache\u201d, Headache<\/i>, 1994\u00a0Jun;34(6):337-43.\r\n\r\nPaemeleire\u00a0K., Louis\u00a0P., Magis\u00a0D., Vandenheede\u00a0M., Versijpt\u00a0J., Vandersmissen\u00a0B. et Schoenen\u00a0J., \u201cDiagnosis, pathophysiology and management of chronic migraine: a proposal of the Belgian Headache Society\u201d, Acta Neurol Belg<\/i>, 2015\u00a0Mar;115(1):1-17.\r\n\r\nPaemeleire\u00a0K., Magis\u00a0D. et Schoenen\u00a0J., \u201cMedical treatment of migraine\u201d, in Reference Module in Neuroscience and Biobehavioral Psychology<\/i>, Elsevier, 2017, pp.\u00a01-5.\r\n\r\nP\u00e1rdutz\u00a0A. et Schoenen\u00a0J., \u201cNSAIDs in the acute treatment of migraine: a review of clinical and experimental data\u201d, Pharmaceuticals<\/i>, 2010;3:1966-1987.\r\n\r\nPohl\u00a0H., Do\u00a0T.P., Garc\u00eda-Azor\u00edn\u00a0D., Hansen\u00a0J.M., Kristoffersen\u00a0E.S., Nelson\u00a0S.E., Obermann\u00a0M., Sandor\u00a0P.S., Schankin\u00a0C.J., Schytz\u00a0H.W., Sinclair\u00a0A., Schoonman\u00a0G.G. et Gantenbein\u00a0A.R., \u201cGreen Flags and headache: A concept study using the Delphi method\u201d, Headache<\/i>, 2021\u00a0Feb;61(2):300-309.\r\n\r\nPohl\u00a0H., Gantenbein\u00a0A.R., Sandor\u00a0P.S., Schoenen\u00a0J. et Andr\u00e9e\u00a0C., \u201cInterictal Burden of Cluster Headache: Results of the EUROLIGHT Cluster Headache Project, an Internet-Based, Cross-Sectional Study of People With Cluster Headache\u201d, Headache<\/i>, 2020\u00a0Feb;60(2):360-369.\r\n\r\nRadat F, Swendsen J. Psychiatric comorbidity in migraine: a review, Cephalalgi,.<\/i> 2005 Mar;25(3):165-78.\r\n\r\nRelja\u00a0M., Poole\u00a0A.C., Schoenen\u00a0J., Pascual\u00a0J., Lei\u00a0X. et Thompson\u00a0C., \u201cA multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type\u00a0A (BoNTA) for the prophylaxis of episodic migraine headaches\u201d, Cephalalgia<\/i>, 2007;27:492-503.\r\n\r\nReyngoudt\u00a0H., Paemeleire\u00a0K., Descamps\u00a0B., De Deene\u00a0Y. et Achten\u00a0E., \u201c31P-MRS demonstrates a reduction in high-energy phosphates in the occipital lobe of migraine without aura patients\u201d, Cephalalgia<\/i>, 2011\u00a0Sep;31(12):1243-53.\r\n\r\nSacco\u00a0S., Merki-Feld\u00a0G.S., \u00c6gidius\u00a0K.L., Bitzer\u00a0J., Canonico\u00a0M., Kurth\u00a0T., Lampl\u00a0C., Lidegaard\u00a0\u00d8., MacGregor\u00a0E.A., Maassen van den Brink\u00a0A., Mitsikostas\u00a0D.D., Nappi\u00a0R.E., Ntaios\u00a0G., Sandset\u00a0P.M. et Martelletti\u00a0P., \u201cEuropean Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)\u201d, J\u00a0Headache Pain<\/i>, 2017\u00a0Oct\u00a030;18(1):108.\r\n\r\nSajobi\u00a0T.T., Amoozegar\u00a0F., Wang\u00a0M., Wiebe\u00a0N., Fiest\u00a0K.M., Patten\u00a0S.B. et Jette\u00a0N., \u201cGlobal assessment of migraine severity measure: preliminary evidence of construct validity\u201d, BMC Neurol<\/i>, 2019\u00a0Apr\u00a04;19(1):53.\r\n\r\nS\u00e1ndor\u00a0P.S., Agosti\u00a0R.M. et Schoenen\u00a0J., \u201cMigraine\u00a0\u2013\u00a0advances in genetic research and possible link to neurophysiological abnormalities\u201d, Schweizer Archiv f\u00fcr Neurologie und Psychiatrie<\/i>, 2001;152:183-193.\r\n\r\nS\u00e1ndor\u00a0P.S., Di Clemente\u00a0M., Coppola\u00a0G., Saenger\u00a0U., Fumal\u00a0A., Magis\u00a0D., Seidel\u00a0L., Agosti\u00a0R.M. et Schoenen\u00a0J., \u201cEfficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial\u201d, Neurology<\/i>, 2005;64:713-15.\r\n\r\nScher\u00a0A.I., Stewart\u00a0W.F., Ricci\u00a0J.A. et Lipton\u00a0R.B., \u201cFactors associated with the onset and remission of chronic daily headache in a population-based study\u201d, Pain<\/i>, 2003\u00a0Nov;106(1-2):81-9.\r\n\r\nSchoenen\u00a0J., \u00ab\u00a0Les c\u00e9phal\u00e9es p\u00e9rimenstruelles. Contraception\u00a0\u2013\u00a0Fertilit\u00e9\u00a0\u2013\u00a0Sexualit\u00e9\u00a0\u00bb, 1985, 13(5):757-761.\r\n\r\nSchoenen\u00a0J., \u201cPathogenesis of migraine: the biobehavioural and hypoxia theories reconciled\u201d, Acta Neurologica Belgica<\/i>, 1994;94:79-86.\r\n\r\nSchoenen\u00a0J., \u00ab\u00a0\u00c9pid\u00e9miologie et impact de la migraine\u00a0\u00bb, Cahiers de m\u00e9decine du travail<\/i>, 1995, XXXII:203-204.\r\n\r\nSchoenen\u00a0J., \u201cDeficient habituation of evoked cortical potentials in migraine: a link between brain biology, behavior and trigeminovascular activation?\u201d, Biomed & Pharmacother<\/i>, 1996;50:71-78.\r\n\r\nSchoenen\u00a0J., \u201cCluster Headache\u201d, Advanced Studies in Medicine<\/i>, 2001;1:446-448.\r\n\r\nSchoenen\u00a0J., \u201cAre migraine and headache associated with an increased risk of stroke in women?\u201d, Nature Clinical Practice Neurology<\/i>, 2006;2:74-75.\r\n\r\nSchoenen\u00a0J., \u201cBotulinum toxin in headache treatment: finally a promising path?\u201d, Cephalalgia<\/i>, 2010;30:771-773.\r\n\r\nSchoenen\u00a0J. et Ambrosini\u00a0A., \u201cUpdate on noninvasive neuromodulation for migraine treatment-Vagus nerve stimulation\u201d, Prog Brain Res<\/i>, 2020;255:249-274.\r\n\r\nSchoenen\u00a0J., Baschi\u00a0R., Magis\u00a0D. et Coppola\u00a0G., \u201cNoninvasive neurostimulation methods for migraine therapy: The available evidence\u201d, Cephalalgia<\/i>, 2016\u00a0Oct;36(12):1170-1180.\r\n\r\nSchoenen\u00a0J., Bulcke\u00a0J., Caekebeke\u00a0J., Dehaene\u00a0I., De Keyser\u00a0J., Hildebrand\u00a0G., Joffroy\u00a0A., Laloux\u00a0P., Louis\u00a0P., Monseu\u00a0G., Pierre\u00a0P., Vanderlinden\u00a0C., Sautois\u00a0D. et Vanderberghe\u00a0A., \u201cSelf-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device: comparison with customary treatment in an open, longitudinal study\u201d, Cephalalgia<\/i>, 1994;14:55-63.\r\n\r\nSchoenen\u00a0J., Burette\u00a0P. et Materne\u00a0P., \u00ab\u00a0Foramen ovale perm\u00e9able et migraines\u00a0: association fortuite ou relation causale\u00a0?\u00a0\u00bb, Revue m\u00e9dicale de Li\u00e8ge<\/i>, 2006, 61;9-15.\r\n\r\nSchoenen\u00a0J., Di Clemente\u00a0L., Vandenheede\u00a0M., Fumal\u00a0A., De Pasqua\u00a0V., Mouchamps\u00a0M., Remacle\u00a0J.M. et Maertens de Noordhout\u00a0A., \u201cHypothalamic stimulation in chronic cluster headache: a pilot study of efficacy and mode of action\u201d, Brain<\/i>, 2005;128:940-947.\r\n\r\nSchoenen\u00a0J., Dodick\u00a0D.W. et S\u00e1ndor\u00a0P.S., Comorbidity in Migraine<\/i>, Oxford, Eds Wiley-Blackwell Publishing Ltd, 2011, 142\u00a0p.\r\n\r\nSchoenen\u00a0J., Franco\u00a0G., Schretlen\u00a0L. et Sobocki\u00a0P., \u201cCost estimates of brain disorders in Belgium\u201d, Acta Neurologica Belgica<\/i>, 2006;106:208-214.\r\n\r\nSchoenen\u00a0J., Jacquy\u00a0J. et Lenaerts\u00a0M., \u201cEffectiveness of high-dose riboflavin in migraine prophylaxis: a randomized controlled trial\u201d, Neurology<\/i>, 1998;50:466-470.\r\n\r\nSchoenen\u00a0J., Jensen\u00a0R.H., Lant\u00e9ri-Minet\u00a0M., L\u00e1inez\u00a0M.J., Gaul\u00a0C., Goodman\u00a0A.M., Caparso\u00a0A. et May\u00a0A., \u201cStimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway\u00a0CH-1: A randomized, sham-controlled study\u201d, Cephalalgia<\/i>, 2013\u00a0Jul;33(10):816-30.\r\n\r\nSchoenen\u00a0J., Lecart\u00a0M.P. et Morlion\u00a0B., \u00ab\u00a0C\u00e9phal\u00e9es et facialgies\u00a0\u00bb, in \u00c2ge et douleur\u00a0: un guide pratique<\/i>, \u00e9ds B.\u00a0Morlion, M.P.\u00a0Lecart, H.\u00a0Verschueren et E.\u00a0Vanduynhoven, Lannoo Campus, 2011, pp.\u00a0155-165.\r\n\r\nSchoenen\u00a0J., Lenarduzzi\u00a0P. et Sianard-Gainko\u00a0J., \u201cChronic headaches associated with analgesics and\/or ergotamine abuse: a clinical survey of 434\u00a0consecutive out-patients\u201d, in New Advances in Headache Research<\/i>, F.\u00a0Clifford Rose, ed.\u00a0Smith-Gordon, 1989, pp.\u00a0255-259.\r\n\r\nSchoenen\u00a0J., Manise\u00a0M., Nonis\u00a0R., Ge\u0301rard\u00a0P. et Timmermans\u00a0G., \u201cMonoclonal antibodies blocking CGRP transmission: an update on their added value in migraine prevention\u201d, Revue Neurologique<\/i>, Paris, 2020;176:788-803.\r\n\r\nSchoenen\u00a0J. et Olesen\u00a0J. (co-ed.), \u201cTension-type Headache: classification, mechanisms and treatment\u201d, Frontiers in Headache Research<\/i>, Vol.\u00a03, New York, Raven Press, 1993, 291\u00a0p.\r\n\r\nSchoenen\u00a0J., Reuter\u00a0U., Diener\u00a0H.C., Pfeil\u00a0J., Schwalen\u00a0S., Schauble\u00a0B. et van Oene\u00a0J., \u201cFactors predicting the probability of relapse after discontinuation of migraine preventive treatment with topiramate\u201d, Cephalalgia<\/i>, 2010; 30:1290-1295.\r\n\r\nSchoenen\u00a0J. et S\u00e1ndor\u00a0P., \u201cHeadache\u201d, in Handbook of Pain Management<\/i>, Eds R.\u00a0Melzack et P.D.\u00a0Wall, Chap.\u00a033, London, Churchill Livingstone, 2003.\r\n\r\nSchoenen\u00a0J. et Sava\u00a0S., \u201cTension-type Headache\u201d, in Wall and Melzack\u2019s Textbook of Pain<\/i>, 6th<\/sup>\u00a0Ed., eds S.\u00a0MacMahon, M.\u00a0Koltzenburg, I.\u00a0Tracey et D.\u00a0Turk, Chap.59, Elsevier, Amsterdam, 2013.\r\n\r\nSchoenen\u00a0J., Timmermans\u00a0G., Nonis\u00a0R., Manise\u00a0M., Fumal\u00a0A. et G\u00e9rard\u00a0P., \u201cErenumab for migraine prevention in a 1-year compassionate use program: efficacy, tolerability and differences between clinical phenotypes\u201d (soumis pour publication).\r\n\r\nSchoenen\u00a0J., Vandersmissen\u00a0B., Jeangette\u00a0S., Herroelen\u00a0L., Vandenheede\u00a0M., G\u00e9rard\u00a0P. et Magis\u00a0D., \u201cMigraine prevention with a supraorbital transcutaneous stimulator: A randomized controlled trial\u201d, Neurology<\/i>, 2013;80:697-704.\r\n\r\nSchoenen\u00a0J., Wang\u00a0W., Albert\u00a0A. et Delwaide\u00a0P.J., \u201cPotentiation instead of habituation characterizes visual evoked potentials in migraine patients between attacks\u201d, European Journal of Neurology<\/i>, 1995;2:115-122.\r\n\r\nSchulte\u00a0L.H. et May\u00a0A., \u201cThe migraine generator revisited: continuous scanning of the migraine cycle over 30\u00a0days and three spontaneous attacks\u201d, Brain<\/i>, 2016\u00a0Jul;139(Pt\u00a07):1987-93.\r\n\r\nSch\u00fcrks\u00a0M., Rist\u00a0P.M., Bigal\u00a0M.E., Buring\u00a0J.E., Lipton\u00a0R.B. et Kurth\u00a0T., \u201cMigraine and cardiovascular disease: systematic review and meta-analysis\u201d, BMJ<\/i>, 2009\u00a0Oct\u00a027;339:b3914.\r\n\r\nSchwedt\u00a0T.J. et Schoenen\u00a0J., \u201cPatent foramen ovale and Migraine\u201d, in Comorbidity in Migraine<\/i>, Chapter\u00a04, Eds Schoenen\u00a0J., Dodick\u00a0D.W. et S\u00e1ndor\u00a0P.S., Oxford, Wiley-Blackwell Publishing Ltd, 2011, 142\u00a0p., pp.\u00a041-59.\r\n\r\nShapiro\u00a0R.E., \u201cWhat Will it Take to Move the Needle for Headache Disorders? An Advocacy Perspective\u201d, Headache<\/i>, 2020\u00a0Oct;60(9):2059-2077.\r\n\r\nSilberstein\u00a0S.D., Latsko\u00a0M. et Schoenen\u00a0J., \u201cPreventive Antimigraine Drugs\u201d, in Multidisciplinary Management of Migraine<\/i>, Chap\u00a010, Eds C.\u00a0Fernandez-de-las-Pe\u00f1as, L.\u00a0Chaitow et J.\u00a0Schoenen, Contemporary issues in Physical therapy and Rehabilitation Medicine<\/i>, Jones and Bartlett Learning, Burlington (USA), 2012, pp.\u00a091-102.\r\n\r\nSomerville\u00a0B.W., \u201cThe role of estradiol withdrawal in the etiology of menstrual migraine\u201d, Neurology<\/i>, 1972\u00a0Apr;22(4):355-65.\r\n\r\nStreel\u00a0S., Donneau\u00a0A.F., Dardenne\u00a0N., Hoge\u00a0A., Albert\u00a0A., Schoenen\u00a0J. et Guillaume\u00a0M., \u201cScreening for the metabolic syndrome in subjects with migraine\u201d, Cephalalgia<\/i>, 2017\u00a0Oct;37(12):1180-1188.\r\n\r\nStreel\u00a0S., Donneau\u00a0A.F., Hoge\u00a0A., Albert\u00a0A., Schoenen\u00a0J. et Guillaume\u00a0M., \u201cOne-year prevalence of migraine using a validated extended French version of the ID Migraine\u2122: A Belgian population-based study\u201d, Rev Neurol<\/i>, Paris, 2015\u00a0Oct;171(10):707-14.\r\n\r\nSwerts\u00a0D.B., Benedetti\u00a0F. et Peres\u00a0M.F.P., \u201cDifferent routes of administration in chronic migraine prevention lead to different placebo responses: a meta-analysis\u201d, Pain<\/i>, 2021\u00a0Jun\u00a014, doi:10.1097\/j.pain.0000000000002365.\r\n\r\nTfelt-Hansen\u00a0P., Dahlof\u00a0C., Pascual\u00a0J., Lainez\u00a0M., Henry\u00a0P., Diener\u00a0H.C., Schoenen\u00a0J., Ferrari\u00a0M.D., Saxena\u00a0P.R. et Goadsby\u00a0P.J., \u201cErgotamine: current place in the treatment of acute migraine attacks\u00a0\u2013\u00a0European Consensus\u201d, Brain<\/i>, 2000;123:9-18.\r\n\r\nTodd\u00a0J., \u201cThe syndrome of Alice in Wonderland\u201d, Can Med Assoc\u00a0J., 1955;73(9).\r\n\r\nVan den Bergh\u00a0V., Amery\u00a0W.K. et Waelkens\u00a0J., \u201cTrigger factors in migraine: a study conducted by the Belgian Migraine Society\u201d, Headache<\/i>, 1987\u00a0Apr;27(4):191-6.\r\n\r\nVarkey\u00a0E., Cider\u00a0A., Carlsson\u00a0J. et Linde\u00a0M., \u201cExercise as migraine prophylaxis: a randomized study using relaxation and topiramate as controls\u201d, Cephalalgia<\/i>, 2011\u00a0Oct;31(14):1428-38.\r\n\r\nVigano\u00a0A., Sasso d\u2019Elia\u00a0T., Sava\u00a0S.L., Auv\u00e9\u00a0M., De Pasqua\u00a0V., Colosimo\u00a0A., Di Piero\u00a0V., Schoenen\u00a0J. et Magis\u00a0D., \u201cTranscranial Direct Current Stimulation (tDCS) of the visual cortex: a proof-of-concept study based on interictal electrophysiological abnormalities in migraine\u201d, Journal of Headache and Pain<\/i>, 2013;14:23-31.\r\n\r\nWaldie\u00a0K.E., Hausmann\u00a0M., Milne\u00a0B.J. et Poulton\u00a0R., \u201cMigraine and cognitive function: a life-course study\u201d, Neurology<\/i>, 2002\u00a0Sep\u00a024;59(6):904-8.\r\n\r\nWare\u00a0J.E.\u00a0Jr et Sherbourne\u00a0C.D., \u201cThe MOS 36-item short-form health survey (SF-36). I.\u00a0Conceptual framework and item selection\u201d, Med Care<\/i>, 1992\u00a0Jun;30(6):473-83.\r\n\r\nWells\u00a0R.E., O\u2019Connell\u00a0N., Pierce\u00a0C.R., Estave\u00a0P., Penzien\u00a0D.B., Loder\u00a0E., Zeidan\u00a0F. et Houle\u00a0T.T., \u201cEffectiveness of Mindfulness Meditation vs Headache Education for Adults With Migraine: A Randomized Clinical Trial\u201d, JAMA Intern Med<\/i>, 2021\u00a0Mar\u00a01;181(3):317-328.\r\n\r\nWhitmarsh\u00a0T.E., Coleston-Shields\u00a0D.M. et Steiner\u00a0T.J., \u201cDouble-blind randomized placebo-controlled study of homoeopathic prophylaxis of migraine\u201d, Cephalalgia<\/i>, 1997\u00a0Aug;17(5):600-4.\r\n\r\nWijga\u00a0A.H., Gehring\u00a0U., van de Putte\u00a0E.M., Koppelman\u00a0G.H., Vader\u00a0S., Schmits\u00a0R.J.H., van der Wouden\u00a0J.C. et Picavet\u00a0H.S.J., \u201cHeadache in girls and boys growing up from age\u00a011 to 20\u00a0years: the Prevention and Incidence of Asthma and Mite Allergy birth cohort study\u201d, Pain<\/i>, 2021\u00a0May\u00a01;162(5):1449-1456.\r\n\r\nWijman\u00a0C.A., Wolf\u00a0P.A., Kase\u00a0C.S., Kelly-Hayes\u00a0M. et Beiser\u00a0A.S., \u201cMigrainous visual accompaniments are not rare in late life: the Framingham Study\u201d, Stroke<\/i>, 1998\u00a0Aug;29(8):1539-43.\r\n\r\nZanchin\u00a0G., \u201cHeadache: an historical outline\u201d, Chapter\u00a025, Handb Clin Neurol<\/i>, 2010;95:375-86.","rendered":"

\u00c1fra\u00a0J., S\u00e1ndor\u00a0P.S. et Schoenen\u00a0J., \u201cHabituation of visual and intensity dependence of auditory evoked cortical potentials tend to normalize just before and during the migraine attack\u201d, Cephalalgia<\/i>, 2000;20:714-719.<\/p>\n

Ambrosini\u00a0A., de Noordhout\u00a0A.M., Sandor\u00a0P.S. et Schoenen\u00a0J., \u201cElectrophysiological studies in migraine: a comprehensive review of their interest and limitations\u201d, Cephalalgia<\/i>, 2003;23:13-31.<\/p>\n

Ambrosini\u00a0A. et Schoenen\u00a0J., \u201cInvasive pericranial nerve interventions\u201d, Cephalalgia<\/i>, 2016\u00a0Oct;36(12):1156-1169.<\/p>\n

Ambrosini\u00a0A., Vandenheede\u00a0M., Rossi\u00a0P., Aloj\u00a0F., Sauli\u00a0E., Pierelli\u00a0F. et Schoenen\u00a0J., \u201cSuboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: a double-blind placebo-controlled study\u201d, Pain<\/i>, 2005;118:92-6.<\/p>\n

Amundsen\u00a0S., Nordeng\u00a0H., Nezvalov\u00e1-Henriksen\u00a0K., Stovner\u00a0L.J. et Spigset\u00a0O., \u201cPharmacological treatment of migraine during pregnancy and breastfeeding\u201d, Nat Rev Neurol<\/i>, 2015\u00a0Apr;11(4):209-19.<\/p>\n

Ashina\u00a0M., \u201cMigraine\u201d, N Engl J Med<\/i>, 2020\u00a0Nov\u00a05;383(19):1866-1876.<\/p>\n

Ashina\u00a0M., Buse\u00a0D.C., Ashina\u00a0H., Pozo-Rosich\u00a0P., Peres\u00a0M.F.P., Lee\u00a0M.J., Terwindt\u00a0G.M., Halker Singh\u00a0R., Tassorelli\u00a0C., Do\u00a0T.P., Mitsikostas\u00a0D.D. et Dodick\u00a0D.W., \u201cMigraine: integrated approaches to clinical management and emerging treatments\u201d, Lancet<\/i>, 2021\u00a0Apr\u00a017;397(10283):1505-1518.<\/p>\n

Barrett\u00a0C.F., van den Maagdenberg\u00a0A.M.J.M., Frants\u00a0R.R. et Ferrari\u00a0M.D., \u201cFamilial hemiplegic migraine\u201d, Adv Genet<\/i>, 2008;63:57-83.<\/p>\n

Bendik\u00a0E.M., Tinkle\u00a0B.T., Al-Shuik\u00a0E., Levin\u00a0L., Martin\u00a0A., Thaler\u00a0R., Atzinger\u00a0C.L., Rueger\u00a0J. et Martin\u00a0V.T., \u201cJoint hypermobility syndrome: A common clinical disorder associated with migraine in women\u201d, Cephalalgia<\/i>, 2011\u00a0Apr;31(5):603-13.<\/p>\n

Bogdanov\u00a0V.B., Multon\u00a0S., Chauvel\u00a0V., Bogdanova\u00a0O.V., Prodanov\u00a0D., Makarchuk\u00a0M.Y. et Schoenen\u00a0J., \u201cMigraine preventive drugs differentially affect cortical spreading depression in rat\u201d, Neurobiology of Disease<\/i>, 2011;41:430-435.<\/p>\n

Bogdanov\u00a0V.B., Vigan\u00f2\u00a0A., Noirhomme\u00a0Q., Bogdanova\u00a0O.V., Guy\u00a0N., Laureys\u00a0S., Renshaw\u00a0P.F., Dallel\u00a0R., Phillips\u00a0C. et Schoenen\u00a0J., \u201cCerebral responses and role of the prefrontal cortex in conditioned pain modulation: an fMRI study in healthy subjects\u201d, Behav Brain Res<\/i>, 2015\u00a0Mar\u00a015;281:187-98.<\/p>\n

Breslau N, Davis GC. Migraine, physical health and psychiatric disorder: a prospective epidemiologic study in young adults, J Psychiatr Res.,<\/i> 1993 Apr-Jun;27(2):211-21.<\/p>\n

Burch\u00a0R., Rizzoli\u00a0P. et Loder\u00a0E., \u201cThe prevalence and impact of migraine and severe headache in the United States: Updated age, sex, and socioeconomic-specific estimates from government health surveys\u201d, Headache<\/i>, 2021\u00a0Jan;61(1):60-68.<\/p>\n

Burstein\u00a0R., Noseda\u00a0R. et Fulton\u00a0A.B., \u201cNeurobiology of Photophobia\u201d, J\u00a0Neuroophthalmol<\/i>, 2019\u00a0Mar;39(1):94-102.<\/p>\n

Chalmer\u00a0M.A., Esserlind\u00a0A.L., Olesen\u00a0J. et Hansen\u00a0T.F., \u00ab\u00a0Polygenic risk score: use in migraine research\u00a0\u00bb, J\u00a0Headache Pain<\/i>, 2018\u00a0Apr\u00a05;19(1):29.<\/p>\n

Charles\u00a0A., et Hansen\u00a0J.M., \u201cMigraine aura: new ideas about cause, classification, and clinical significance\u201d, Curr Opin Neurol<\/i>, 2015\u00a0Jun;28(3):255-60.<\/p>\n

Chauvel\u00a0V., Multon\u00a0S. et Schoenen\u00a0J., \u201cEstrogen-dependent effects of 5-hydroxytryptophan on cortical spreading depression in rat: modelling the serotonin-ovarian hormone interaction in migraine aura\u201d, Cephalalgia<\/i>, 2018\u00a0Mar;38(3):427-436.<\/p>\n

Chauvel\u00a0V., Schoenen\u00a0J. et Multon\u00a0S. (J.S. and S.M. contributed equally to this work<\/i>), \u201cInfluence of Ovarian Hormones on Cortical Spreading Depression and Its Suppression by L-kynurenine in Rat\u201d, PLoS ONE<\/i>, 2013;8(12): e82279.<\/p>\n

Choquet\u00a0H., Yin\u00a0J., Jacobson\u00a0A.S., Horton\u00a0B.H., Hoffmann\u00a0T.J., Jorgenson\u00a0E., Avins\u00a0A.L. et Pressman\u00a0A.R., \u201cNew and sex-specific migraine susceptibility loci identified from a multiethnic genome-wide meta-analysis\u201d, Commun Biol<\/i>, 2021\u00a0Jul\u00a022;4(1):864.<\/p>\n

Chou\u00a0D.E., Shnayderman Yugrakh\u00a0M., Winegarner\u00a0D., Rowe\u00a0V., Kuruvilla\u00a0D. et Schoenen\u00a0J., \u201cAcute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial\u201d, Cephalalgia<\/i>, 2019\u00a0Jan;39(1):3-14.<\/p>\n

Coppola\u00a0G., Di Lenola\u00a0D., Abagnale\u00a0C., Ferrandes\u00a0F., Sebastianelli\u00a0G., Casillo\u00a0F., Di Lorenzo\u00a0C., Serrao\u00a0M., Evangelista\u00a0M., Schoenen\u00a0J. et Pierelli\u00a0F., \u201cShort-latency afferent inhibition and somato-sensory evoked potentials during the migraine cycle: surrogate markers of a cycling cholinergic thalamo-cortical drive?\u201d, J\u00a0Headache Pain<\/i>, 2020\u00a0Apr\u00a016;21(1):34.<\/p>\n

Delvaux\u00a0V., Vandenheede\u00a0M. et Schoenen\u00a0J., \u00ab\u00a0C\u00e9phal\u00e9es explosives, \u201cen coup de tonnerre\u201d\u00a0: faut-il s\u2019inqui\u00e9ter\u00a0?\u00a0\u00bb, Revue m\u00e9dicale de Li\u00e8ge<\/i>, 2000, 55:910-914.<\/p>\n

Demarquay\u00a0G., Moisset\u00a0X., Lant\u00e9ri-Minet\u00a0M., de Gaalon\u00a0S., Donnet\u00a0A., Giraud\u00a0P., Gu\u00e9gan-Massardier\u00a0E., Lucas\u00a0C., Mawet\u00a0J., Roos\u00a0C., Valade\u00a0D. et Ducros\u00a0A., \u201cRevised guidelines of the French Headache Society for the diagnosis and management of migraine in adults. Part\u00a01: Diagnosis and assessment\u201d, Rev.\u00a0Neurol.<\/i>, Paris, 2021\u00a0Sep;177(7):725-733.<\/p>\n

Denuelle\u00a0M., Fabre\u00a0N., Payoux\u00a0P., Chollet\u00a0F. et Geraud\u00a0G., \u201cHypothalamic activation in spontaneous migraine attacks\u201d, Headache<\/i>, 2007\u00a0Nov-Dec;47(10):1418-26.<\/p>\n

Di Lorenzo\u00a0C., Pinto\u00a0A., Ienca\u00a0R., Coppola\u00a0G., Sirianni\u00a0G., Di Lorenzo\u00a0G., Parisi\u00a0V., Serrao\u00a0M., Spagnoli\u00a0A., Vestri\u00a0A., Schoenen\u00a0J., Donini\u00a0L.M. et Pierelli\u00a0F., \u201cA Randomized Double-Blind, Cross-Over Trial of very Low-Calorie Diet in Overweight Migraine Patients: A Possible Role for Ketones?\u201d, Nutrients<\/i>, 2019\u00a0Jul\u00a028;11(8):1742.<\/p>\n

Di Stefano\u00a0G., Yuan\u00a0J.H., Cruccu\u00a0G., Waxman\u00a0S.G., Dib-Hajj\u00a0S.D. et Truini\u00a0A., \u201cFamilial trigeminal neuralgia\u00a0\u2013\u00a0a systematic clinical study with a genomic screen of the neuronal electrogenisome\u201d, Cephalalgia<\/i>, 2020\u00a0Jul;40(8):767-777.<\/p>\n

Diener\u00a0H.C., Dodick\u00a0D., Evers\u00a0S., Holle\u00a0D., Jensen\u00a0R.H., Lipton\u00a0R.B., Porreca\u00a0F., Silberstein\u00a0S. et Schwedt\u00a0T., \u201cPathophysiology, prevention, and treatment of medication overuse headache\u201d, Lancet Neurol<\/i>, 2019\u00a0Sep;18(9):891-902.<\/p>\n

Diener\u00a0H.C., MacGregor\u00a0E.A., Schoenen\u00a0J., Steiner\u00a0T.J., Muirhead\u00a0N. et Sikes\u00a0C., \u201cComparison of the efficacy and safety of eletriptan and zolmitriptan for the acute treatment of migraine: results of a multicenter, multi-dose, randomised clinical trial\u201d, Neurology<\/i>, 2002, 58, Suppl.\u00a03, A290:P04.081.<\/p>\n

Dodick\u00a0D.W., \u201cCGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications\u201d, Cephalalgia<\/i>, 2019\u00a0Mar;39(3):445-458.<\/p>\n

Drellia\u00a0K., Kokoti\u00a0L., Deligianni\u00a0C.I., Papadopoulos\u00a0D. et Mitsikostas\u00a0D.D., \u00ab\u00a0Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis\u00a0\u00bb, Cephalalgia<\/i>, 2021\u00a0Jun;41(7):851-864.<\/p>\n

Ducros\u00a0A., de Gaalon\u00a0S., Roos\u00a0C., Donnet\u00a0A., Giraud\u00a0P., Gu\u00e9gan-Massardier\u00a0E., Lant\u00e9ri-Minet\u00a0M., Lucas\u00a0C., Mawet\u00a0J., Moisset\u00a0X., Valade\u00a0D. et Demarquay\u00a0G., \u201cRevised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part\u00a02: Pharmacological treatment\u201d, Rev Neurol<\/i>, Paris, 2021\u00a0Sep;177(7):734-752.<\/p>\n

Eadie\u00a0M.J., \u201cHubert Airy, contemporary men of science and the migraine aura\u201d, J\u00a0R\u00a0Coll Physicians Edinb., 2009;39:263-7.<\/p>\n

Edmeads\u00a0J., L\u00e1inez\u00a0J.M., Brandes\u00a0J.L., Schoenen\u00a0J. et Freitag\u00a0F., \u201cPotential of the migraine disability assessment (MIDAS) questionnaire as a public health initiative and in clinical practice\u201d, Neurology<\/i>, 2001, 56 (Suppl\u00a01):S29-S34.<\/p>\n

Edvinsson\u00a0L., Haanes\u00a0K.A., Warfvinge\u00a0K. et Krause\u00a0D.N., \u00ab\u00a0CGRP as the target of new migraine therapies\u00a0\u2013\u00a0successful translation from bench to clinic\u00a0\u00bb, Nat Rev Neurol<\/i>, 2018;14(6):338-350.<\/p>\n

Eigenbrodt\u00a0A.K., Ashina\u00a0H., Khan\u00a0S., Diener\u00a0H.C., Mitsikostas\u00a0D.D., Sinclair\u00a0A.J., Pozo-Rosich\u00a0P., Martelletti\u00a0P., Ducros\u00a0A., Lant\u00e9ri-Minet\u00a0M., Braschinsky\u00a0M., Del Rio\u00a0M.S., Daniel\u00a0O., \u00d6zge\u00a0A., Mammadbayli\u00a0A., Arons\u00a0M., Skorobogatykh\u00a0K., Romanenko\u00a0V., Terwindt\u00a0G.M., Paemeleire\u00a0K., Sacco\u00a0S., Reuter\u00a0U., Lampl\u00a0C., Schytz\u00a0H.W., Katsarava\u00a0Z., Steiner\u00a0T.J. et Ashina\u00a0M., \u201cDiagnosis and management of migraine in ten steps\u201d, Nat Rev Neurol<\/i>, 2021\u00a0Aug;17(8):501-514.<\/p>\n

F\u00e4rkkil\u00e4\u00a0M., Diener\u00a0H.C., G\u00e9raud\u00a0G., L\u00e1inez\u00a0M., Schoenen\u00a0J., Harner\u00a0N., Pilgrim\u00a0A. et Reuter\u00a0U. (for the COL\u00a0MIG-202 study group), \u201cEfficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase\u00a02 randomised, placebo-controlled, parallel-group, dose-ranging study\u201d, Lancet Neurology<\/i>, 2012;11:405-413.<\/p>\n

Fern\u00e1ndez-de-las-Pe\u00f1as\u00a0C., Chaitow\u00a0L. et Schoenen\u00a0J., \u201cMultidsiciplinary Management of Migraine: Pharmacological, Manual And Other Therapies\u201d, Ed. Jones and Bartlett Learning (USA), Contemporary issues in physical therapy and rehabilitation medicine<\/i>, 2012, 414\u00a0p.<\/p>\n

Fern\u00e1ndez-de-Las-Pe\u00f1as\u00a0C. et Cuadrado\u00a0M.L., \u201cPhysical therapy for headaches\u201d, Cephalalgia<\/i>, 2016\u00a0Oct;36(12):1134-1142.<\/p>\n

Fogang\u00a0Y., G\u00e9rard\u00a0P., De Pasqua\u00a0V., Pepin\u00a0J.L., Ndiaye\u00a0M., Magis\u00a0D. et Schoenen\u00a0J., \u201cAnalysis and clinical correlates of 20\u00a0Hz photic driving on routine EEG in migraine\u201d, Acta Neurol Belg<\/i>, 2015\u00a0Mar;115(1):39-45.<\/p>\n

Fontana\u00a0A., \u00ab\u00a0Essai contr\u00f4l\u00e9 randomis\u00e9\u00a0: quelle est la plus-value de l\u2019assistance vid\u00e9o lors de s\u00e9ances d\u2019\u00e9ducation th\u00e9rapeutique chez les patients migraineux\u00a0\u00bb, M\u00e9moire de fin d\u2019\u00e9tudes de Master en sciences de la sant\u00e9 publique, ULg, ann\u00e9e acad\u00e9mique 2018-2019.<\/p>\n

Fumal\u00a0A., Laureys\u00a0S., Di Clemente\u00a0L., Boly\u00a0M., Bohotin\u00a0V., Vandenheede\u00a0M., Coppola\u00a0G., Salmon\u00a0E., Kupers\u00a0R. et Schoenen\u00a0J., \u201cOrbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine\u201d, Brain<\/i>, 2006;129:543-50.<\/p>\n

Fumal\u00a0A., Magis\u00a0D. et Schoenen\u00a0J., \u00ab\u00a0Les c\u00e9phal\u00e9es par abus d\u2019antalgiques\u00a0\u00bb, Revue m\u00e9dicale de Li\u00e8ge<\/i>, 2006, 61(4):217-222.<\/p>\n

Gaul\u00a0C., S\u00e1ndor\u00a0P.S., Galli\u00a0U., Palla\u00a0S. et Ettlin\u00a0D.A., \u201cOrofacial migraine\u201d, Cephalalgia<\/i>, 2007\u00a0Aug;27(8)\u00a0:950-2.<\/p>\n

George\u00a0K.M., Folsom\u00a0A.R., Sharrett\u00a0A.R., Mosley\u00a0T.H., Gottesman\u00a0R.F., Hamedani\u00a0A.G. et Lutsey\u00a0P.L., \u201cMigraine Headache and Risk of Dementia in the Atherosclerosis Risk in Communities Neurocognitive Study\u201d, Headache<\/i>, 2020\u00a0May;60(5):946-953.<\/p>\n

G\u00e9rardy\u00a0P.-Y., Fumal\u00a0A. et Schoenen\u00a0J., \u00ab\u00a0\u00c9pid\u00e9miologie et r\u00e9percussions \u00e9conomiques des c\u00e9phal\u00e9es\u00a0: une enqu\u00eate parmi le personnel administratif, technique et ouvrier (PATO) de l\u2019Universit\u00e9 de Li\u00e8ge\u00a0\u00bb, Revue m\u00e9dicale de Li\u00e8ge<\/i>, 2008, 63\u00a0:310-314.<\/p>\n

Global burden of 369\u00a0diseases and injuries in 204\u00a0countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019, GBD\u00a02019 Diseases and Injuries Collaborators, Lancet, 2020\u00a0Oct\u00a017;396(10258):1204-1222.<\/p>\n

Gross\u00a0E.C., Klement\u00a0R.J., Schoenen\u00a0J., D\u2019Agostino\u00a0D.P. et Fischer\u00a0D., \u201cPotential Protective Mechanisms of Ketone Bodies in Migraine Prevention\u201d, Nutrients<\/i>, 2019\u00a0Apr\u00a010;11(4):811.<\/p>\n

Gross\u00a0E.C., Lisicki\u00a0M., Fischer\u00a0D., S\u00e1ndor\u00a0P.S. et Schoenen\u00a0J., \u201cThe metabolic face of migraine\u00a0\u2013\u00a0from pathophysiology to treatment\u201d, Nat Rev Neurol<\/i>, 2019\u00a0Nov;15(11):627-643.<\/p>\n

Headache Classification Committee of the International Headache Society (IHS), The International Classification of Headache Disorders<\/i>, 3rd<\/sup>\u00a0ed., Cephalalgia, 2018\u00a0Jan;38(1):1-211.<\/p>\n

Hepp\u00a0Z., Dodick\u00a0D.W., Varon\u00a0S.F., Chia\u00a0J., Matthew\u00a0N., Gillard\u00a0P., Hansen\u00a0R.N. et Devine\u00a0E.B., \u201cPersistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis\u201d, Cephalalgia<\/i>, 2017\u00a0Apr;37(5):470-485.<\/p>\n

Holroyd\u00a0K.A., Cottrell\u00a0C.K., O\u2019Donnell\u00a0F.J., Cordingley\u00a0G.E., Drew\u00a0J.B., Carlson\u00a0B.W. et Himawan\u00a0L., \u201cEffect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial\u201d, BMJ<\/i>, 2010\u00a0Sep\u00a029;341:c4871.<\/p>\n

Horton\u00a0B.T., MacLean\u00a0A.R. et Craig\u00a0W.M., \u201cA new syndrome of vascular headache: results of treatment with histamine: preliminary report\u201d, Mayo Clinic Proceedings<\/i>, 1939;14:257.<\/p>\n

Juprelle\u00a0M. et Schoenen\u00a0J., \u00ab\u00a0Relaxation avec biofeedback<\/i> musculaire dans les c\u00e9phal\u00e9es de type tension\u00a0: analyse multifactorielle d\u2019un groupe de 31\u00a0patients\u00a0\u00bb, Revue m\u00e9dicale de Li\u00e8ge<\/i>, 1990;45:630-637.<\/p>\n

Kelman\u00a0L., \u201cThe triggers or precipitants of the acute migraine attack\u201d, Cephalalgia<\/i>, 2007\u00a0May;27(5):394-402.<\/p>\n

Kosinski\u00a0M., Bayliss\u00a0M.S., Bjorner\u00a0J.B. et\u00a0al<\/i>., \u201cA six\u2010item short\u2010form survey for measuring headache impact: The HIT\u20106\u201d, Qual Life Res<\/i>, 2003;12:963\u2010974.<\/p>\n

Kostev\u00a0K., Bohlken\u00a0J. et Jacob\u00a0L., \u201cAssociation Between Migraine Headaches and Dementia in More than 7,400\u00a0Patients Followed in General Practices in the United Kingdom\u201d, J\u00a0Alzheimers Dis<\/i>, 2019;71(1):353-360.<\/p>\n

Kurth\u00a0T. et Diener\u00a0H.C., \u201cCurrent views of the risk of stroke for migraine with and migraine without aura\u201d, Curr Pain Headache Rep<\/i>, 2006\u00a0Jun;10(3):214-20.<\/p>\n

Kurth\u00a0T., Rist\u00a0P.M., Ridker\u00a0P.M., Kotler\u00a0G., Bubes\u00a0V. et Buring\u00a0J.E., \u201cAssociation of Migraine With Aura and Other Risk Factors With Incident Cardiovascular Disease in Women\u201d, JAMA<\/i>, 2020\u00a0Jun\u00a09;323(22):2281-2289.<\/p>\n

Kurth\u00a0T., Winter\u00a0A.C., Eliassen\u00a0A.H., Dushkes\u00a0R., Mukamal\u00a0K.J., Rimm\u00a0E.B., Willett\u00a0W.C., Manson\u00a0J.E. et Rexrode\u00a0K.M., \u201cMigraine and risk of cardiovascular disease in women: prospective cohort study\u201d, BMJ<\/i>, 2016\u00a0May\u00a031;353:i2610.<\/p>\n

Laakso\u00a0S.M., Hekali\u00a0O., Kurdo\u00a0G., Martola\u00a0J., Sairanen\u00a0T. et Atula\u00a0S., \u201cTrigeminal neuralgia in multiple sclerosis: Prevalence and association with demyelination\u201d, Acta Neurol Scand<\/i>, 2020\u00a0Aug;142(2):139-144.<\/p>\n

Lanteri-Minet\u00a0M., Valade\u00a0D., Geraud\u00a0G., Lucas\u00a0C. et Donnet\u00a0A., \u201cRevised French guidelines for the diagnosis and management of migraine in adults and children\u201d, J\u00a0Headache Pain<\/i>, 2014\u00a0Jan\u00a08;15(1):2.<\/p>\n

Lauritzen\u00a0M., \u201cCortical spreading depression in migraine\u201d, Cephalalgia<\/i>, 2001\u00a0Sep;21(7):757-60.<\/p>\n

Lempert\u00a0T., Olesen\u00a0J., Furman\u00a0J., Waterston\u00a0J., Seemungal\u00a0B., Carey\u00a0J., Bisdorff\u00a0A., Versino\u00a0M., Evers\u00a0S. et Newman-Toker\u00a0D., \u00ab\u00a0Vestibular migraine: diagnostic criteria\u00a0\u00bb, J\u00a0Vestib Res<\/i>, 2012;22(4):167-72.<\/p>\n

Linde\u00a0K., Allais\u00a0G., Brinkhaus\u00a0B., Fei\u00a0Y., Mehring\u00a0M., Vertosick\u00a0E.A., Vickers\u00a0A. et White\u00a0A.R., \u201cAcupuncture for the prevention of episodic migraine\u201d, Cochrane Database Syst Rev<\/i>, 2016\u00a0Jun\u00a028;2016(6):CD001218.<\/p>\n

Lipton\u00a0R.B., Bigal\u00a0M.E., Ashina\u00a0S., Burstein\u00a0R., Silberstein\u00a0S., Reed\u00a0M.L., Serrano\u00a0D. et Stewart\u00a0W.F., \u201cAmerican Migraine Prevalence Prevention Advisory Group. Cutaneous allodynia in the migraine population\u201d, Ann Neurol<\/i>, 2008\u00a0Feb;63(2):148-58.<\/p>\n

Lipton\u00a0R.B., Cady\u00a0R.K., Stewart\u00a0W.F., Wilks\u00a0K. et Hall\u00a0C., \u201cDiagnostic lessons from the spectrum study\u201d, Neurology<\/i>, 2002\u00a0May\u00a014;58(9\u00a0Suppl\u00a06):S27-31.<\/p>\n

Lipton\u00a0R.B., Scher\u00a0A.I., Kolodner\u00a0K., Liberman\u00a0J., Steiner\u00a0T.J. et Stewart\u00a0W.F., \u201cMigraine in the United States: epidemiology and patterns of health care use\u201d, Neurology<\/i>, 2002;58:885-894.<\/p>\n

Lisicki\u00a0M. et Schoenen\u00a0J., \u201cMetabolic treatments of migraine\u201d, Expert Review of Neurotherapeutics<\/i>, 2020;20(3):295-302.<\/p>\n

Lisicki\u00a0M. et Schoenen\u00a0J., \u201cOld habits die hard: Dietary patterns of migraine patients challenge our understanding of dietary triggers\u201d, Front Neurol<\/i>, 2021 (sous presse).<\/p>\n

Lipton\u00a0R.B., Stewart\u00a0W.F., Sawyer\u00a0J. et Edmeads\u00a0J.G., \u201cClinical utility of an instrument assessing migraine disability: the Migraine Disability Assessment (MIDAS) questionnaire\u201d, Headache<\/i>, 2001\u00a0Oct;41(9):854-61.<\/p>\n

Lisicki\u00a0M., D\u2019Ostilio\u00a0K., Coppola\u00a0G., Scholtes\u00a0F., Maertens de Noordhout\u00a0A., Parisi\u00a0V., Schoenen\u00a0J. et Magis\u00a0D., \u201cEvidence of an increased neuronal activation-to-resting glucose uptake ratio in the visual cortex of migraine patients: a study comparing 18FDG-PET and visual evoked potentials\u201d, J\u00a0Headache Pain<\/i>, 2018\u00a0Jul\u00a05;19(1):49.<\/p>\n

Loder\u00a0E.W., \u201cMenstrual migraine: pathophysiology, diagnosis, and impact\u201d, Headache<\/i>, 2006\u00a0Oct;46\u00a0Suppl\u00a02:S55-60.<\/p>\n

MacGregor\u00a0E.A., \u201cMenstrual migraine\u201d, Curr Opin Neurol<\/i>, 2008\u00a0Jun;21(3):309-15.<\/p>\n

Maertens de Noordhout\u00a0A. et Schoenen\u00a0J., \u00ab\u00a0Les algies faciales\u00a0\u00bb, Revue m\u00e9dicale de Li\u00e8ge<\/i>, 1986, XLI(9)\u00a0:342-348.<\/p>\n

Maertens de Noordhout\u00a0A., Timsit\u00a0M., Timsit-Berthier\u00a0M. et Schoenen\u00a0J., \u201cContingent Negative Variation in Headache\u201d, Annals of Neurology<\/i>, 1986;19:78-80.<\/p>\n

Magis\u00a0D., Gerardy\u00a0P.Y., Remacle\u00a0J.M. et Schoenen\u00a0J., \u201cSustained effectiveness of occipital nerve stimulation in drug-resistant chronic cluster headache\u201d, Headache<\/i>, 2011;51:1191-201.<\/p>\n

Magis\u00a0D. et Schoenen\u00a0J., \u201cMigraine: from genetics to environment\u201d, Revue m\u00e9dicale de Li\u00e8ge<\/i>, 2012, 67:349-358.<\/p>\n

Manack\u00a0A.N., Buse\u00a0D.C. et Lipton\u00a0R.B., \u201cChronic migraine: epidemiology and disease burden\u201d, Curr Pain Headache Rep<\/i>, 2011\u00a0Feb;15(1):70-8.<\/p>\n

Mitsikostas\u00a0D.D., Mantonakis\u00a0L.I. et Chalarakis\u00a0N.G., \u00ab\u00a0Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches\u00a0\u00bb, Cephalalgia<\/i>, 2011\u00a0Apr;31(5):550-61.<\/p>\n

Moens\u00a0G., Johannik\u00a0K., Verbeek\u00a0C. et Bulterys\u00a0S., \u201cThe prevalence and characteristics of migraine among the Belgian working population\u201d, Acta Neurol Belg<\/i>, 2007\u00a0Sep;107(3):84-90.<\/p>\n

Moskowitz\u00a0M.A., \u201cThe neurobiology of vascular head pain\u201d, Ann Neurol<\/i>, 1984\u00a0Aug;16(2):157-68.<\/p>\n

Nappi\u00a0R.E., Sances\u00a0G., Allais\u00a0G., Terreno\u00a0E., Benedetto\u00a0C., Vaccaro\u00a0V., Polatti\u00a0F. et Facchinetti\u00a0F., \u201cEffects of an estrogen-free, desogestrel-containing oral contraceptive in women with migraine with aura: a prospective diary-based pilot study\u201d, Contraception<\/i>, 2011\u00a0Mar;83(3):223-8.<\/p>\n

Obermann\u00a0M., Yoon\u00a0M.S., Dommes\u00a0P., Kuznetsova\u00a0J., Maschke\u00a0M., Weimar\u00a0C., Limmroth\u00a0V., Diener\u00a0H.C. et Katsarava\u00a0Z., \u201cPrevalence of trigeminal autonomic symptoms in migraine: a population-based study\u201d, Cephalalgia<\/i>, 2007\u00a0Jun;27(6):504-9.<\/p>\n

Olesen\u00a0J., Diener\u00a0H.C., Schoenen\u00a0J. et Hettiarachchi\u00a0J., \u201cNo effect of eletriptan administration during the aura phase of migraine\u201d, Europ J Neurol<\/i>, 2004;11:671-677.<\/p>\n

Osterhaus\u00a0J.T., Townsend\u00a0R.J., Gandek\u00a0B. et Ware\u00a0J.E.\u00a0Jr., \u201cMeasuring the functional status and well-being of patients with migraine headache\u201d, Headache<\/i>, 1994\u00a0Jun;34(6):337-43.<\/p>\n

Paemeleire\u00a0K., Louis\u00a0P., Magis\u00a0D., Vandenheede\u00a0M., Versijpt\u00a0J., Vandersmissen\u00a0B. et Schoenen\u00a0J., \u201cDiagnosis, pathophysiology and management of chronic migraine: a proposal of the Belgian Headache Society\u201d, Acta Neurol Belg<\/i>, 2015\u00a0Mar;115(1):1-17.<\/p>\n

Paemeleire\u00a0K., Magis\u00a0D. et Schoenen\u00a0J., \u201cMedical treatment of migraine\u201d, in Reference Module in Neuroscience and Biobehavioral Psychology<\/i>, Elsevier, 2017, pp.\u00a01-5.<\/p>\n

P\u00e1rdutz\u00a0A. et Schoenen\u00a0J., \u201cNSAIDs in the acute treatment of migraine: a review of clinical and experimental data\u201d, Pharmaceuticals<\/i>, 2010;3:1966-1987.<\/p>\n

Pohl\u00a0H., Do\u00a0T.P., Garc\u00eda-Azor\u00edn\u00a0D., Hansen\u00a0J.M., Kristoffersen\u00a0E.S., Nelson\u00a0S.E., Obermann\u00a0M., Sandor\u00a0P.S., Schankin\u00a0C.J., Schytz\u00a0H.W., Sinclair\u00a0A., Schoonman\u00a0G.G. et Gantenbein\u00a0A.R., \u201cGreen Flags and headache: A concept study using the Delphi method\u201d, Headache<\/i>, 2021\u00a0Feb;61(2):300-309.<\/p>\n

Pohl\u00a0H., Gantenbein\u00a0A.R., Sandor\u00a0P.S., Schoenen\u00a0J. et Andr\u00e9e\u00a0C., \u201cInterictal Burden of Cluster Headache: Results of the EUROLIGHT Cluster Headache Project, an Internet-Based, Cross-Sectional Study of People With Cluster Headache\u201d, Headache<\/i>, 2020\u00a0Feb;60(2):360-369.<\/p>\n

Radat F, Swendsen J. Psychiatric comorbidity in migraine: a review, Cephalalgi,.<\/i> 2005 Mar;25(3):165-78.<\/p>\n

Relja\u00a0M., Poole\u00a0A.C., Schoenen\u00a0J., Pascual\u00a0J., Lei\u00a0X. et Thompson\u00a0C., \u201cA multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type\u00a0A (BoNTA) for the prophylaxis of episodic migraine headaches\u201d, Cephalalgia<\/i>, 2007;27:492-503.<\/p>\n

Reyngoudt\u00a0H., Paemeleire\u00a0K., Descamps\u00a0B., De Deene\u00a0Y. et Achten\u00a0E., \u201c31P-MRS demonstrates a reduction in high-energy phosphates in the occipital lobe of migraine without aura patients\u201d, Cephalalgia<\/i>, 2011\u00a0Sep;31(12):1243-53.<\/p>\n

Sacco\u00a0S., Merki-Feld\u00a0G.S., \u00c6gidius\u00a0K.L., Bitzer\u00a0J., Canonico\u00a0M., Kurth\u00a0T., Lampl\u00a0C., Lidegaard\u00a0\u00d8., MacGregor\u00a0E.A., Maassen van den Brink\u00a0A., Mitsikostas\u00a0D.D., Nappi\u00a0R.E., Ntaios\u00a0G., Sandset\u00a0P.M. et Martelletti\u00a0P., \u201cEuropean Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)\u201d, J\u00a0Headache Pain<\/i>, 2017\u00a0Oct\u00a030;18(1):108.<\/p>\n

Sajobi\u00a0T.T., Amoozegar\u00a0F., Wang\u00a0M., Wiebe\u00a0N., Fiest\u00a0K.M., Patten\u00a0S.B. et Jette\u00a0N., \u201cGlobal assessment of migraine severity measure: preliminary evidence of construct validity\u201d, BMC Neurol<\/i>, 2019\u00a0Apr\u00a04;19(1):53.<\/p>\n

S\u00e1ndor\u00a0P.S., Agosti\u00a0R.M. et Schoenen\u00a0J., \u201cMigraine\u00a0\u2013\u00a0advances in genetic research and possible link to neurophysiological abnormalities\u201d, Schweizer Archiv f\u00fcr Neurologie und Psychiatrie<\/i>, 2001;152:183-193.<\/p>\n

S\u00e1ndor\u00a0P.S., Di Clemente\u00a0M., Coppola\u00a0G., Saenger\u00a0U., Fumal\u00a0A., Magis\u00a0D., Seidel\u00a0L., Agosti\u00a0R.M. et Schoenen\u00a0J., \u201cEfficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial\u201d, Neurology<\/i>, 2005;64:713-15.<\/p>\n

Scher\u00a0A.I., Stewart\u00a0W.F., Ricci\u00a0J.A. et Lipton\u00a0R.B., \u201cFactors associated with the onset and remission of chronic daily headache in a population-based study\u201d, Pain<\/i>, 2003\u00a0Nov;106(1-2):81-9.<\/p>\n

Schoenen\u00a0J., \u00ab\u00a0Les c\u00e9phal\u00e9es p\u00e9rimenstruelles. Contraception\u00a0\u2013\u00a0Fertilit\u00e9\u00a0\u2013\u00a0Sexualit\u00e9\u00a0\u00bb, 1985, 13(5):757-761.<\/p>\n

Schoenen\u00a0J., \u201cPathogenesis of migraine: the biobehavioural and hypoxia theories reconciled\u201d, Acta Neurologica Belgica<\/i>, 1994;94:79-86.<\/p>\n

Schoenen\u00a0J., \u00ab\u00a0\u00c9pid\u00e9miologie et impact de la migraine\u00a0\u00bb, Cahiers de m\u00e9decine du travail<\/i>, 1995, XXXII:203-204.<\/p>\n

Schoenen\u00a0J., \u201cDeficient habituation of evoked cortical potentials in migraine: a link between brain biology, behavior and trigeminovascular activation?\u201d, Biomed & Pharmacother<\/i>, 1996;50:71-78.<\/p>\n

Schoenen\u00a0J., \u201cCluster Headache\u201d, Advanced Studies in Medicine<\/i>, 2001;1:446-448.<\/p>\n

Schoenen\u00a0J., \u201cAre migraine and headache associated with an increased risk of stroke in women?\u201d, Nature Clinical Practice Neurology<\/i>, 2006;2:74-75.<\/p>\n

Schoenen\u00a0J., \u201cBotulinum toxin in headache treatment: finally a promising path?\u201d, Cephalalgia<\/i>, 2010;30:771-773.<\/p>\n

Schoenen\u00a0J. et Ambrosini\u00a0A., \u201cUpdate on noninvasive neuromodulation for migraine treatment-Vagus nerve stimulation\u201d, Prog Brain Res<\/i>, 2020;255:249-274.<\/p>\n

Schoenen\u00a0J., Baschi\u00a0R., Magis\u00a0D. et Coppola\u00a0G., \u201cNoninvasive neurostimulation methods for migraine therapy: The available evidence\u201d, Cephalalgia<\/i>, 2016\u00a0Oct;36(12):1170-1180.<\/p>\n

Schoenen\u00a0J., Bulcke\u00a0J., Caekebeke\u00a0J., Dehaene\u00a0I., De Keyser\u00a0J., Hildebrand\u00a0G., Joffroy\u00a0A., Laloux\u00a0P., Louis\u00a0P., Monseu\u00a0G., Pierre\u00a0P., Vanderlinden\u00a0C., Sautois\u00a0D. et Vanderberghe\u00a0A., \u201cSelf-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device: comparison with customary treatment in an open, longitudinal study\u201d, Cephalalgia<\/i>, 1994;14:55-63.<\/p>\n

Schoenen\u00a0J., Burette\u00a0P. et Materne\u00a0P., \u00ab\u00a0Foramen ovale perm\u00e9able et migraines\u00a0: association fortuite ou relation causale\u00a0?\u00a0\u00bb, Revue m\u00e9dicale de Li\u00e8ge<\/i>, 2006, 61;9-15.<\/p>\n

Schoenen\u00a0J., Di Clemente\u00a0L., Vandenheede\u00a0M., Fumal\u00a0A., De Pasqua\u00a0V., Mouchamps\u00a0M., Remacle\u00a0J.M. et Maertens de Noordhout\u00a0A., \u201cHypothalamic stimulation in chronic cluster headache: a pilot study of efficacy and mode of action\u201d, Brain<\/i>, 2005;128:940-947.<\/p>\n

Schoenen\u00a0J., Dodick\u00a0D.W. et S\u00e1ndor\u00a0P.S., Comorbidity in Migraine<\/i>, Oxford, Eds Wiley-Blackwell Publishing Ltd, 2011, 142\u00a0p.<\/p>\n

Schoenen\u00a0J., Franco\u00a0G., Schretlen\u00a0L. et Sobocki\u00a0P., \u201cCost estimates of brain disorders in Belgium\u201d, Acta Neurologica Belgica<\/i>, 2006;106:208-214.<\/p>\n

Schoenen\u00a0J., Jacquy\u00a0J. et Lenaerts\u00a0M., \u201cEffectiveness of high-dose riboflavin in migraine prophylaxis: a randomized controlled trial\u201d, Neurology<\/i>, 1998;50:466-470.<\/p>\n

Schoenen\u00a0J., Jensen\u00a0R.H., Lant\u00e9ri-Minet\u00a0M., L\u00e1inez\u00a0M.J., Gaul\u00a0C., Goodman\u00a0A.M., Caparso\u00a0A. et May\u00a0A., \u201cStimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway\u00a0CH-1: A randomized, sham-controlled study\u201d, Cephalalgia<\/i>, 2013\u00a0Jul;33(10):816-30.<\/p>\n

Schoenen\u00a0J., Lecart\u00a0M.P. et Morlion\u00a0B., \u00ab\u00a0C\u00e9phal\u00e9es et facialgies\u00a0\u00bb, in \u00c2ge et douleur\u00a0: un guide pratique<\/i>, \u00e9ds B.\u00a0Morlion, M.P.\u00a0Lecart, H.\u00a0Verschueren et E.\u00a0Vanduynhoven, Lannoo Campus, 2011, pp.\u00a0155-165.<\/p>\n

Schoenen\u00a0J., Lenarduzzi\u00a0P. et Sianard-Gainko\u00a0J., \u201cChronic headaches associated with analgesics and\/or ergotamine abuse: a clinical survey of 434\u00a0consecutive out-patients\u201d, in New Advances in Headache Research<\/i>, F.\u00a0Clifford Rose, ed.\u00a0Smith-Gordon, 1989, pp.\u00a0255-259.<\/p>\n

Schoenen\u00a0J., Manise\u00a0M., Nonis\u00a0R., Ge\u0301rard\u00a0P. et Timmermans\u00a0G., \u201cMonoclonal antibodies blocking CGRP transmission: an update on their added value in migraine prevention\u201d, Revue Neurologique<\/i>, Paris, 2020;176:788-803.<\/p>\n

Schoenen\u00a0J. et Olesen\u00a0J. (co-ed.), \u201cTension-type Headache: classification, mechanisms and treatment\u201d, Frontiers in Headache Research<\/i>, Vol.\u00a03, New York, Raven Press, 1993, 291\u00a0p.<\/p>\n

Schoenen\u00a0J., Reuter\u00a0U., Diener\u00a0H.C., Pfeil\u00a0J., Schwalen\u00a0S., Schauble\u00a0B. et van Oene\u00a0J., \u201cFactors predicting the probability of relapse after discontinuation of migraine preventive treatment with topiramate\u201d, Cephalalgia<\/i>, 2010; 30:1290-1295.<\/p>\n

Schoenen\u00a0J. et S\u00e1ndor\u00a0P., \u201cHeadache\u201d, in Handbook of Pain Management<\/i>, Eds R.\u00a0Melzack et P.D.\u00a0Wall, Chap.\u00a033, London, Churchill Livingstone, 2003.<\/p>\n

Schoenen\u00a0J. et Sava\u00a0S., \u201cTension-type Headache\u201d, in Wall and Melzack\u2019s Textbook of Pain<\/i>, 6th<\/sup>\u00a0Ed., eds S.\u00a0MacMahon, M.\u00a0Koltzenburg, I.\u00a0Tracey et D.\u00a0Turk, Chap.59, Elsevier, Amsterdam, 2013.<\/p>\n

Schoenen\u00a0J., Timmermans\u00a0G., Nonis\u00a0R., Manise\u00a0M., Fumal\u00a0A. et G\u00e9rard\u00a0P., \u201cErenumab for migraine prevention in a 1-year compassionate use program: efficacy, tolerability and differences between clinical phenotypes\u201d (soumis pour publication).<\/p>\n

Schoenen\u00a0J., Vandersmissen\u00a0B., Jeangette\u00a0S., Herroelen\u00a0L., Vandenheede\u00a0M., G\u00e9rard\u00a0P. et Magis\u00a0D., \u201cMigraine prevention with a supraorbital transcutaneous stimulator: A randomized controlled trial\u201d, Neurology<\/i>, 2013;80:697-704.<\/p>\n

Schoenen\u00a0J., Wang\u00a0W., Albert\u00a0A. et Delwaide\u00a0P.J., \u201cPotentiation instead of habituation characterizes visual evoked potentials in migraine patients between attacks\u201d, European Journal of Neurology<\/i>, 1995;2:115-122.<\/p>\n

Schulte\u00a0L.H. et May\u00a0A., \u201cThe migraine generator revisited: continuous scanning of the migraine cycle over 30\u00a0days and three spontaneous attacks\u201d, Brain<\/i>, 2016\u00a0Jul;139(Pt\u00a07):1987-93.<\/p>\n

Sch\u00fcrks\u00a0M., Rist\u00a0P.M., Bigal\u00a0M.E., Buring\u00a0J.E., Lipton\u00a0R.B. et Kurth\u00a0T., \u201cMigraine and cardiovascular disease: systematic review and meta-analysis\u201d, BMJ<\/i>, 2009\u00a0Oct\u00a027;339:b3914.<\/p>\n

Schwedt\u00a0T.J. et Schoenen\u00a0J., \u201cPatent foramen ovale and Migraine\u201d, in Comorbidity in Migraine<\/i>, Chapter\u00a04, Eds Schoenen\u00a0J., Dodick\u00a0D.W. et S\u00e1ndor\u00a0P.S., Oxford, Wiley-Blackwell Publishing Ltd, 2011, 142\u00a0p., pp.\u00a041-59.<\/p>\n

Shapiro\u00a0R.E., \u201cWhat Will it Take to Move the Needle for Headache Disorders? An Advocacy Perspective\u201d, Headache<\/i>, 2020\u00a0Oct;60(9):2059-2077.<\/p>\n

Silberstein\u00a0S.D., Latsko\u00a0M. et Schoenen\u00a0J., \u201cPreventive Antimigraine Drugs\u201d, in Multidisciplinary Management of Migraine<\/i>, Chap\u00a010, Eds C.\u00a0Fernandez-de-las-Pe\u00f1as, L.\u00a0Chaitow et J.\u00a0Schoenen, Contemporary issues in Physical therapy and Rehabilitation Medicine<\/i>, Jones and Bartlett Learning, Burlington (USA), 2012, pp.\u00a091-102.<\/p>\n

Somerville\u00a0B.W., \u201cThe role of estradiol withdrawal in the etiology of menstrual migraine\u201d, Neurology<\/i>, 1972\u00a0Apr;22(4):355-65.<\/p>\n

Streel\u00a0S., Donneau\u00a0A.F., Dardenne\u00a0N., Hoge\u00a0A., Albert\u00a0A., Schoenen\u00a0J. et Guillaume\u00a0M., \u201cScreening for the metabolic syndrome in subjects with migraine\u201d, Cephalalgia<\/i>, 2017\u00a0Oct;37(12):1180-1188.<\/p>\n

Streel\u00a0S., Donneau\u00a0A.F., Hoge\u00a0A., Albert\u00a0A., Schoenen\u00a0J. et Guillaume\u00a0M., \u201cOne-year prevalence of migraine using a validated extended French version of the ID Migraine\u2122: A Belgian population-based study\u201d, Rev Neurol<\/i>, Paris, 2015\u00a0Oct;171(10):707-14.<\/p>\n

Swerts\u00a0D.B., Benedetti\u00a0F. et Peres\u00a0M.F.P., \u201cDifferent routes of administration in chronic migraine prevention lead to different placebo responses: a meta-analysis\u201d, Pain<\/i>, 2021\u00a0Jun\u00a014, doi:10.1097\/j.pain.0000000000002365.<\/p>\n

Tfelt-Hansen\u00a0P., Dahlof\u00a0C., Pascual\u00a0J., Lainez\u00a0M., Henry\u00a0P., Diener\u00a0H.C., Schoenen\u00a0J., Ferrari\u00a0M.D., Saxena\u00a0P.R. et Goadsby\u00a0P.J., \u201cErgotamine: current place in the treatment of acute migraine attacks\u00a0\u2013\u00a0European Consensus\u201d, Brain<\/i>, 2000;123:9-18.<\/p>\n

Todd\u00a0J., \u201cThe syndrome of Alice in Wonderland\u201d, Can Med Assoc\u00a0J., 1955;73(9).<\/p>\n

Van den Bergh\u00a0V., Amery\u00a0W.K. et Waelkens\u00a0J., \u201cTrigger factors in migraine: a study conducted by the Belgian Migraine Society\u201d, Headache<\/i>, 1987\u00a0Apr;27(4):191-6.<\/p>\n

Varkey\u00a0E., Cider\u00a0A., Carlsson\u00a0J. et Linde\u00a0M., \u201cExercise as migraine prophylaxis: a randomized study using relaxation and topiramate as controls\u201d, Cephalalgia<\/i>, 2011\u00a0Oct;31(14):1428-38.<\/p>\n

Vigano\u00a0A., Sasso d\u2019Elia\u00a0T., Sava\u00a0S.L., Auv\u00e9\u00a0M., De Pasqua\u00a0V., Colosimo\u00a0A., Di Piero\u00a0V., Schoenen\u00a0J. et Magis\u00a0D., \u201cTranscranial Direct Current Stimulation (tDCS) of the visual cortex: a proof-of-concept study based on interictal electrophysiological abnormalities in migraine\u201d, Journal of Headache and Pain<\/i>, 2013;14:23-31.<\/p>\n

Waldie\u00a0K.E., Hausmann\u00a0M., Milne\u00a0B.J. et Poulton\u00a0R., \u201cMigraine and cognitive function: a life-course study\u201d, Neurology<\/i>, 2002\u00a0Sep\u00a024;59(6):904-8.<\/p>\n

Ware\u00a0J.E.\u00a0Jr et Sherbourne\u00a0C.D., \u201cThe MOS 36-item short-form health survey (SF-36). I.\u00a0Conceptual framework and item selection\u201d, Med Care<\/i>, 1992\u00a0Jun;30(6):473-83.<\/p>\n

Wells\u00a0R.E., O\u2019Connell\u00a0N., Pierce\u00a0C.R., Estave\u00a0P., Penzien\u00a0D.B., Loder\u00a0E., Zeidan\u00a0F. et Houle\u00a0T.T., \u201cEffectiveness of Mindfulness Meditation vs Headache Education for Adults With Migraine: A Randomized Clinical Trial\u201d, JAMA Intern Med<\/i>, 2021\u00a0Mar\u00a01;181(3):317-328.<\/p>\n

Whitmarsh\u00a0T.E., Coleston-Shields\u00a0D.M. et Steiner\u00a0T.J., \u201cDouble-blind randomized placebo-controlled study of homoeopathic prophylaxis of migraine\u201d, Cephalalgia<\/i>, 1997\u00a0Aug;17(5):600-4.<\/p>\n

Wijga\u00a0A.H., Gehring\u00a0U., van de Putte\u00a0E.M., Koppelman\u00a0G.H., Vader\u00a0S., Schmits\u00a0R.J.H., van der Wouden\u00a0J.C. et Picavet\u00a0H.S.J., \u201cHeadache in girls and boys growing up from age\u00a011 to 20\u00a0years: the Prevention and Incidence of Asthma and Mite Allergy birth cohort study\u201d, Pain<\/i>, 2021\u00a0May\u00a01;162(5):1449-1456.<\/p>\n

Wijman\u00a0C.A., Wolf\u00a0P.A., Kase\u00a0C.S., Kelly-Hayes\u00a0M. et Beiser\u00a0A.S., \u201cMigrainous visual accompaniments are not rare in late life: the Framingham Study\u201d, Stroke<\/i>, 1998\u00a0Aug;29(8):1539-43.<\/p>\n

Zanchin\u00a0G., \u201cHeadache: an historical outline\u201d, Chapter\u00a025, Handb Clin Neurol<\/i>, 2010;95:375-86.<\/p>\n","protected":false},"author":1,"menu_order":3,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":[],"pb_section_license":""},"back-matter-type":[],"contributor":[],"license":[],"class_list":["post-102","back-matter","type-back-matter","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/e-publish.uliege.be\/migraine\/wp-json\/pressbooks\/v2\/back-matter\/102"}],"collection":[{"href":"https:\/\/e-publish.uliege.be\/migraine\/wp-json\/pressbooks\/v2\/back-matter"}],"about":[{"href":"https:\/\/e-publish.uliege.be\/migraine\/wp-json\/wp\/v2\/types\/back-matter"}],"author":[{"embeddable":true,"href":"https:\/\/e-publish.uliege.be\/migraine\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":1,"href":"https:\/\/e-publish.uliege.be\/migraine\/wp-json\/pressbooks\/v2\/back-matter\/102\/revisions"}],"predecessor-version":[{"id":103,"href":"https:\/\/e-publish.uliege.be\/migraine\/wp-json\/pressbooks\/v2\/back-matter\/102\/revisions\/103"}],"metadata":[{"href":"https:\/\/e-publish.uliege.be\/migraine\/wp-json\/pressbooks\/v2\/back-matter\/102\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/e-publish.uliege.be\/migraine\/wp-json\/wp\/v2\/media?parent=102"}],"wp:term":[{"taxonomy":"back-matter-type","embeddable":true,"href":"https:\/\/e-publish.uliege.be\/migraine\/wp-json\/pressbooks\/v2\/back-matter-type?post=102"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/e-publish.uliege.be\/migraine\/wp-json\/wp\/v2\/contributor?post=102"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/e-publish.uliege.be\/migraine\/wp-json\/wp\/v2\/license?post=102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}